var title_f11_21_11600="Radiograph of foreign body associated with hand infection";
var content_f11_21_11600=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F66000&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F66000&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Radiograph of foreign body associated with hand infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 354px; height: 540px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A radiograph of the hand should be obtained to document the presence of any foreign bodies. This lateral view radiograph demonstrates embedded pieces of glass.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_21_11600=[""].join("\n");
var outline_f11_21_11600=null;
var title_f11_21_11601="NSCLC hemidiaphragm para";
var content_f11_21_11601=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F75001&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F75001&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Peripheral nerve involvement",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 396px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Left hemidiaphragm paralysis (confirmed by fluoroscopy) in a patient with extensive adenocarcinoma of the lung.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_21_11601=[""].join("\n");
var outline_f11_21_11601=null;
var title_f11_21_11602="Patient information: Pancreatic cancer (The Basics)";
var content_f11_21_11602=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15493\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?12/2/12325\">",
"         Pancreas anatomy",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?36/16/37121\">",
"         Patient information: What are clinical trials? (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?30/9/30865\">",
"         Patient information: ERCP (endoscopic retrograde cholangiopancreatography) (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?30/55/31603\">",
"         Patient information: Pancreatic cancer (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Pancreatic cancer (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/pancreatic-cancer-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H541738682\">",
"      <span class=\"h1\">",
"       What is pancreatic cancer?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Pancreatic cancer happens when normal cells in the pancreas change into abnormal cells and grow out of control. The pancreas is an organ that makes hormones and juices that help the body break down food (",
"      <a class=\"graphic graphic_figure graphicRef53979 \" href=\"UTD.htm?12/2/12325\">",
"       figure 1",
"      </a>",
"      ).",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H541738689\">",
"      <span class=\"h1\">",
"       What are the symptoms of pancreatic cancer?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Symptoms of pancreatic cancer can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Pain &mdash; People can have pain that spreads from their stomach around to their back. The pain can come and go, and it can get worse after eating.",
"       </li>",
"       <li>",
"        Weight loss &mdash; People might not feel hungry, or might feel full after eating very little.",
"       </li>",
"       <li>",
"        Diarrhea &mdash; Bowel movements can look greasy or float in the toilet bowl.",
"       </li>",
"       <li>",
"        Yellowing of the skin, called jaundice &mdash; Both the skin and the white part of the eyes can turn yellow. Jaundice can also cause your bowel movements to look gray instead of brown.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      These symptoms can also be caused by conditions that are not pancreatic cancer. But if you have these symptoms, tell your doctor or nurse about them.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H541738696\">",
"      <span class=\"h1\">",
"       Is there a test for pancreatic cancer?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. If your doctor suspects you have pancreatic cancer, he or she will order one or more tests. These can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Blood tests",
"       </li>",
"       <li>",
"        Ultrasound, CT scan, or other imaging tests &mdash; These tests create pictures of the inside of the body and can show abnormal growths.",
"       </li>",
"       <li>",
"        Biopsy &mdash; A doctor will take a small sample of tissue from the pancreas. Then another doctor will look at the sample under a microscope to check for cancer.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H541738703\">",
"      <span class=\"h1\">",
"       What is cancer staging?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Cancer staging is a way in which doctors find out how far a cancer has spread.",
"     </p>",
"     <p>",
"      The right treatment for you will depend a lot on the stage of your cancer. Your treatment will also depend on your age and other medical problems.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H541738710\">",
"      <span class=\"h1\">",
"       How is pancreatic cancer treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;People with pancreatic cancer may be offered one or more of the following treatments:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Surgery",
"        </strong>",
"        &ndash; Pancreatic cancer can sometimes be treated with surgery to remove the cancer. Before surgery, a doctor might do a procedure called &ldquo;laparoscopy&rdquo;. In a laparoscopy, a doctor will make small cuts in the belly. He or she will put a thin tube with a camera on it inside the belly to check the size and location of the cancer.",
"       </li>",
"       <li>",
"        <strong>",
"         Chemotherapy",
"        </strong>",
"        &ndash; Chemotherapy is the term doctors use to describe a group of medicines that kill cancer cells.",
"       </li>",
"       <li>",
"        <strong>",
"         Radiation therapy",
"        </strong>",
"        &ndash; Radiation kills cancer cells.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Pancreatic cancer can sometimes be cured with treatment. This is most likely in people whose cancer is found at an early stage. Even if your pancreatic cancer cannot be cured, your doctor can treat your symptoms. For example, he or she can prescribe medicine to reduce your pain.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H541738717\">",
"      <span class=\"h1\">",
"       What happens after treatment?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Following treatment, you will be checked every so often to see if the cancer comes back. Follow up tests usually include exams, blood tests, and imaging tests. If the cancer comes back after treatment, you might have chemotherapy or radiation therapy. You might also get pain medicine or other treatments to help with pain.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H541738724\">",
"      <span class=\"h1\">",
"       What else should I do?",
"      </span>",
"      &nbsp;&mdash;&nbsp;It is important to follow all your doctors&rsquo; instructions about visits and tests. It&rsquo;s also important to talk to your doctor about any side effects or problems you have during treatment.",
"     </p>",
"     <p>",
"      Getting treated for pancreatic cancer involves making many choices, such as which treatment to have.",
"     </p>",
"     <p>",
"      Always let your doctors and nurses know how you feel about a treatment. Any time you are offered a treatment, ask:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        What are the benefits of this treatment? Is it likely to help me live longer? Will it reduce or prevent symptoms?",
"       </li>",
"       <li>",
"        What are the downsides to this treatment?",
"       </li>",
"       <li>",
"        Are there other options besides this treatment?",
"       </li>",
"       <li>",
"        What happens if I do not have this treatment?",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H541738731\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/16/37121?source=see_link\">",
"       Patient information: What are clinical trials? (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?30/55/31603?source=see_link\">",
"       Patient information: Pancreatic cancer (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?30/9/30865?source=see_link\">",
"       Patient information: ERCP (endoscopic retrograde cholangiopancreatography) (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?11/21/11602?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15493 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-122.72.76.133-D31E40A6FC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_21_11602=[""].join("\n");
var outline_f11_21_11602=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H541738682\">",
"      What is pancreatic cancer?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H541738689\">",
"      What are the symptoms of pancreatic cancer?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H541738696\">",
"      Is there a test for pancreatic cancer?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H541738703\">",
"      What is cancer staging?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H541738710\">",
"      How is pancreatic cancer treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H541738717\">",
"      What happens after treatment?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H541738724\">",
"      What else should I do?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H541738731\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15493\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?12/2/12325\">",
"      Pancreas anatomy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/9/30865?source=related_link\">",
"      Patient information: ERCP (endoscopic retrograde cholangiopancreatography) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/55/31603?source=related_link\">",
"      Patient information: Pancreatic cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/16/37121?source=related_link\">",
"      Patient information: What are clinical trials? (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_21_11603="Papillary thyroid cancer FNA";
var content_f11_21_11603=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F71385&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F71385&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Papillary thyroid cancer: Findings on fine needle aspirate",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 239px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Fine needle aspirate of a thyroid nodule showing papillary cancer. The cells and nuclei are large, and their cytoplasm has a \"ground glass\" appearance. Nucleoli are prominent and the nuclei have clefts, grooves, and \"holes\" due to intranuclear cytoplasmic inclusions (\"Orphan Annie eyes\").",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_21_11603=[""].join("\n");
var outline_f11_21_11603=null;
var title_f11_21_11604="Ioversol: Patient drug information";
var content_f11_21_11604=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Ioversol: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/57/34709?source=see_link\">",
"     see \"Ioversol: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F184022\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Optiray&reg; 240;",
"     </li>",
"     <li>",
"      Optiray&reg; 300;",
"     </li>",
"     <li>",
"      Optiray&reg; 320;",
"     </li>",
"     <li>",
"      Optiray&reg; 350",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F15793706\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Optiray&reg; 240;",
"     </li>",
"     <li>",
"      Optiray&reg; 300;",
"     </li>",
"     <li>",
"      Optiray&reg; 320;",
"     </li>",
"     <li>",
"      Optiray&reg; 350",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10025455\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700621",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is given as a shot into a vein or artery only.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10025457\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691287",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used before an x-ray or an alike test.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10025456\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702319",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to ioversol or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697128",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a contrast dye allergy, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703164",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an iodine allergy, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10025460\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have thyroid disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10025461\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698277",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Neck pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698249",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Muscle pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698328",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Unsafe allergic effects may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10025463\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698619",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in strength on 1 side is greater than the other, trouble speaking or thinking, change in balance, or blurred eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10025459\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696097",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you by a doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694819",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids after the test is over unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10025464\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10025465\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12215 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-8BB6C55152-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_21_11604=[""].join("\n");
var outline_f11_21_11604=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F184022\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15793706\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025455\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025457\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025456\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025460\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025461\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025463\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025459\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025464\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025465\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?33/57/34709?source=related_link\">",
"      Ioversol: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_21_11605="Hydroxyethyl starch (tetrastarch) 130/0.4: Pediatric drug information";
var content_f11_21_11605=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Hydroxyethyl starch (tetrastarch) 130/0.4: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?29/60/30661?source=see_link\">",
"    see \"Hydroxyethyl starch (tetrastarch) 130/0.4: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?18/46/19171?source=see_link\">",
"    see \"Hydroxyethyl starch (tetrastarch) 130/0.4: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F10074407\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Voluven&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F10074408\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Volulyte&reg;;",
"     </li>",
"     <li>",
"      Voluven&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F10485746\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Plasma Volume Expander, Colloid",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F15578078\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     With severe dehydration, administer crystalloid first. Dose and rate of infusion dependent on amount of blood lost, on maintenance or restoration of hemodynamics, and on amount of hemodilution. Titrate to individual colloid needs, hemodynamics, and hydration status.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Volume expansion:",
"     </b>",
"     I.V. infusion: Usual range: 7-25 mL/kg/dose; maximum daily dose: 50 mL/kg/",
"     <b>",
"      day",
"     </b>",
"     ; in clinical trials of intraoperative use, a dose of 10 mL/kg/dose has been reported (Osthaus, 2008; Witt, 2008)",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F10485754\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?29/60/30661?source=see_link\">",
"      see \"Hydroxyethyl starch (tetrastarch) 130/0.4: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     With severe dehydration, administer crystalloid first. Dose and rate of infusion dependent on amount of blood lost, on maintenance or restoration of hemodynamics, and on amount of hemodilution. Titrate to individual colloid needs, hemodynamics, and hydration status.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Infants, Children, and Adolescents:",
"     <b>",
"      Volume expansion:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Infants and Children &lt;2 years: I.V. infusion: Usual range:  7-25 mL/kg/dose; mean reported dose: 16 &plusmn; 9 mL/kg/dose; maximum daily dose: 50 mL/kg/",
"     <b>",
"      day",
"     </b>",
"     ; in clinical trials of intraoperative use, a dose of 10 mL/kg/dose has been  reported (Chong Sung, 2006; Osthaus, 2008; Witt, 2008).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children 2-12 years: I.V. infusion:  Usual range: 25-47 mL/kg/dose; mean reported dose: 36 &plusmn; 11 mL/kg/dose; maximum daily dose: 50 mL/kg/",
"     <b>",
"      day",
"     </b>",
"     ; in clinical trials of intraoperative use, a dose of 10 mL/kg/dose has been reported (Chong Sung, 2006; Osthaus, 2008; Witt, 2008).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Adolescents &gt;12 years: I.V. Infusion: Administer up to 50 mL/kg/",
"     <b>",
"      day",
"     </b>",
"     (or up to 3500 mL daily in a 70 kg patient); may administer repetitively over several days.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adults:",
"     <b>",
"      Volume expansion:",
"     </b>",
"     I.V. infusion: Administer up to 50 mL/kg/",
"     <b>",
"      day",
"     </b>",
"     (or up to 3500 mL daily in a 70 kg patient); may administer repetitively over several days.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosing adjustment in renal impairment:",
"     </b>",
"     No dosage adjustments provided in manufacturer&rsquo;s labeling; closely monitor volume status, infusion rate, and urine output. Use is contraindicated in oliguric/anuric renal failure unrelated to hypovolemia and patients receiving hemodialysis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosing adjustment in hepatic impairment:",
"     </b>",
"     No dosage adjustments provided in manufacturer&rsquo;s labeling; use with caution in severe impairment.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F10074457\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infusion, premixed in NS:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Voluven&reg;: 6% (500 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F10074410\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F10927865\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer I.V. only. Infuse the first 10-20 mL slowly to observe for anaphylaxis; have epinephrine and resuscitative equipment available. Change I.V. tubing at least once every 24 hours.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F10485751\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at 15&deg;C to 25&deg;C (59&deg;F to 77&deg;F); do not freeze; use only if solution is clear and free from particles.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F10485747\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment and prophylaxis of hypovolemia (FDA approved in all ages);",
"     <b>",
"      Note:",
"     </b>",
"     This is not a substitute for blood or plasma; does not have oxygen-carrying capacity.",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F10074425\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dermatologic: Pruritus (dose dependent; may be delayed), rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gastrointestinal: Amylase levels increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hematologic: Anemia, aPTT increased, coagulation factors prolonged, hemorrhage from wound site, PT prolonged",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rare but important or life-threatening:  Acute kidney injury, anaphylactic reaction, anaphylactoid reaction, bradycardia, bronchospasm, circulatory collapse, flu-like syndrome, hypersensitivity reaction, hypotension, pulmonary edema (noncardiac), shock, tachycardia",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F10485748\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to hydroxyethyl starch or any component; fluid overload (eg, pulmonary edema and CHF), intracranial bleeding, renal failure with oliguria or anuria (not related to hypovolemia), dialysis, or severe hypernatremia or hyperchloremia",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F10486644\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with severe liver disease or bleeding disorders; may result in further reduction of coagulation factors, increasing the risk of bleeding. Use with caution in patients with renal impairment; fluid status including urine output should be monitored closely; use is contraindicated with oliguria or anuria unrelated to hypovolemia or patients receiving hemodialysis. May temporarily increase serum amylase concentrations.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F10485749\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Anaphylactoid reactions (eg, mild influenza-like symptoms, bradycardia, tachycardia, bronchospasm, noncardiac pulmonary edema) to hydroxyethyl starch solutions have been reported; if signs of hypersensitivity occur, discontinue use immediately and administer appropriate therapy. Administration of large volume may cause a reduction in hematocrit, coagulation factors, and other plasma proteins due to hemodilution; coagulation may be impaired (eg, prolonged PT, PTT, and clotting times) and a transient prolongation of bleeding time may be observed. Administration may cause fluid overload; use with caution in patients at risk from overexpansion of blood volume, including the very young or aged patients and those with CHF or pulmonary edema. Monitor fluid status and rate of infusion periodically with use; in cases of severe dehydration, crystalloid should be administered first.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     The use of hydroxyethyl starches (HES), including tetrastarch, is associated with an increased risk of acute kidney injury in both pediatric and adult patients (Reinhart, 2012). Additionally, in a meta-analysis of mixed critically ill patient populations, the use of HES did not demonstrate statistically significant differences in mortality compared to crystalloid therapy (Perel, 2011). In review of clinical trials including adult patients with severe sepsis or septic shock, a meta-analysis of HES trials demonstrated a trend toward increased mortality (Zarychanski, 2009). In adult patients with severe sepsis, a trend towards higher mortality at 90 days was observed in one clinical trial comparing HES 200/0.5 (pentastarch) to Ringer&rsquo;s lactate (Brunkhorst, 2008). In addition, the use of HES 130/0.42 (Tetraspan&reg;; similar to tetrastarch) has been shown to increase mortality in adult patients with severe sepsis as compared to Ringer&rsquo;s acetate (Perner, 2012). The Society of Critical Care Medicine has recommended either crystalloid or iso-oncotic colloid (natural or artificial) therapy for fluid resuscitation in patients with septic shock (Dellinger, 2008). Hyperoncotic solutions should not be used for fluid resuscitation (Reinhart, 2012).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300129\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F10140508\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F10074416\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F14079782\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events have been observed in animal reproduction studies.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F10485756\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blood pressure, heart rate, capillary refill time, CVP, RAP, MAP; if pulmonary artery catheter in place, monitor cardiac index, PCWP, SVR, and PVR; hemoglobin, coagulation parameters, renal function, urine output, acid-base balance",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F10485752\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Tetrastarch is a synthetic polymer that acts as an oncotic agent to produce plasma volume expansion by virtue of its highly colloidal starch structure.",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F10485766\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Duration of action: &ge;6 hours",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F10485753\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Distribution: 5.9 L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metabolism: Molecules &gt;50,000 daltons are metabolized by plasma &alpha;-amylase",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life: 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Elimination: Urine [smaller hydroxyethyl starch (&lt;50,000 daltons) unchanged, metabolites]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Clearance: 31.4 mL/minute",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F10485758\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Voluven&reg;: 6% hetastarch (130/0.4) in 0.9% sodium chloride",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Molecular weight: ~130,000",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Sodium: 154 mEq/L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Chloride: 154 mEq/L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Osmolarity: 308 mOsm/L",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Brunkhorst FM, Engel C, Bloos F, et al, &ldquo;Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      ,  2008, 358(2):125-39.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/21/11605/abstract-text/18184958/pubmed\" id=\"18184958\" target=\"_blank\">",
"        18184958",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chong Sung K, Kum Suk P, Mi Ja Y, et al, \"Effects of Intravascular Volume Therapy Using Hydroxyethyl Starch (130/0.4) on Post-Operative Bleeding and Transfusion Requirements in Children Undergoing Cardiac Surgery: A Randomized Clinical Trial,\"",
"      <i>",
"       Acta Anaesthesiol Scand",
"      </i>",
"      , 2006, 50(1):108-11.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/21/11605/abstract-text/16451158/pubmed\" id=\"16451158\" target=\"_blank\">",
"        16451158",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dellinger RP, Levy MM, Carlet JM, et al, &ldquo;Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2008,&rdquo;",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 2008, 36(1):296-327; published erratum appears in",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 2008, 36(4):1394-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/21/11605/abstract-text/18158437/pubmed\" id=\"18158437\" target=\"_blank\">",
"        18158437",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hanart C, Khalife M, De Vill&eacute; A, et al, \"Perioperative Volume Replacement in Children Undergoing Cardiac Surgery: Albumin Versus Hydroxyethyl Starch 130/0.4,\"",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 2009, 37(2):696-701.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/21/11605/abstract-text/19114887/pubmed\" id=\"19114887\" target=\"_blank\">",
"        19114887",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lochbuhler H, Galli C, and Hagemann H, \"Hydroxylethyl Starch HES 130/0.4 in Paediatric Surgery: Results on an Explorative, Controlled, Multicenter Safety Study,\"",
"      <i>",
"       Crit Care",
"      </i>",
"      , 2003, 7(2 Suppl): 107.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Osthaus WA, Witt L, Johanning K, et al, \"Equal Effects of Gelatin and Hydroxyethyl Starch (6% HES 130/0.42) on Modified Thrombelastography in Children,\"",
"      <i>",
"       Acta Anaesthesiol Scand",
"      </i>",
"      , 2009, 53(3):305-10.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/21/11605/abstract-text/19173690/pubmed\" id=\"19173690\" target=\"_blank\">",
"        19173690",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Perel P and Roberts I, &ldquo;Colloids versus Crystalloids for Fluid Resuscitation in Critically Ill Patients,&rdquo;",
"      <i>",
"       Cochrane Database Syst Rev",
"      </i>",
"      , 2012, 6:CD000567.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/21/11605/abstract-text/22696320/pubmed\" id=\"22696320\" target=\"_blank\">",
"        22696320",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Perner A, Haase N, Guttormsen AB, et al, &ldquo;Hydroxyethyl Starch 130/0.4 versus Ringer&rsquo;s Acetate in Severe Sepsis,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2012, 367(2):124-34; published erratum appears in",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2012, 367(5):481.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/21/11605/abstract-text/22738085/pubmed\" id=\"22738085\" target=\"_blank\">",
"        22738085",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Reinhart K, Perner A, Sprung CL, et al, &ldquo;Consensus Statement of the ESICM Task Force on Colloid Volume Therapy in Critically Ill Patients,&rdquo;",
"      <i>",
"       Intensive Care Med",
"      </i>",
"      , 2012, 38(3):368-83.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/21/11605/abstract-text/22323076/pubmed\" id=\"22323076\" target=\"_blank\">",
"        22323076",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      S&uuml;mpelmann R, Kretz FJ, G&auml;bler R, et al, \"Hydroxyethyl Starch 130/0.42/6:1 for Perioperative Plasma Volume Replacement in Children: Preliminary Results of a European Prospective Multicenter Observational Postauthorization Safety Study (PASS),\"",
"      <i>",
"       Paediatr Anaesth",
"      </i>",
"      , 2008, 18(10):929-33.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/21/11605/abstract-text/18647272/pubmed\" id=\"18647272\" target=\"_blank\">",
"        18647272",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Witt L, Osthaus WA, J&uuml;ttner B, et al, \"Alteration of Anion Gap and Strong Ion Difference Caused by Hydroxyethyl Starch 6% (130/0.42) and Gelatin 4% in Children,\"",
"      <i>",
"       Paediatr Anaesth",
"      </i>",
"      , 2008, 18(10):934-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/21/11605/abstract-text/18811828/pubmed\" id=\"18811828\" target=\"_blank\">",
"        18811828",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Zarychanski R, Turgeon AF, Fergusson DA, et al, &ldquo;Renal Outcomes and Mortality Following Hydroxyethyl Starch Resuscitation of Critically Ill Patients: Systematic Review and Meta-Analysis of Randomized Trials&rdquo;",
"      <b>",
"       ATTENTION:",
"      </b>",
"      The analysis and conclusions of this article are being revised by the authors. This is due to the journal Anesthesia and Analgesia's retraction of a paper by Dr. Joachim Boldt, an author in seven of the studies analyzed in this review. As such, the editors of Open Medicine recommend interpreting this review with extreme caution until Zarychanski et al. publish a new analysis and interpretation in Open Medicine. For more information, see Anesthesia and Analgesia's press release. Open Med, 2009, 3(4):e196-209.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/21/11605/abstract-text/21688756/pubmed\" id=\"21688756\" target=\"_blank\">",
"        21688756",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16069 Version 22.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-91.202.164.29-18C9BB78CB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_21_11605=[""].join("\n");
var outline_f11_21_11605=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10074407\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10074408\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10485746\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15578078\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10485754\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10074457\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10074410\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10927865\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10485751\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10485747\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10074425\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10485748\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10486644\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10485749\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300129\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10140508\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10074416\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14079782\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10485756\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10485752\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10485766\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10485753\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10485758\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/16069\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/16069|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?29/60/30661?source=related_link\">",
"      Hydroxyethyl starch (tetrastarch) 130/0.4: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?18/46/19171?source=related_link\">",
"      Hydroxyethyl starch (tetrastarch) 130/0.4: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_21_11606="Nateglinide: Drug information";
var content_f11_21_11606=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Nateglinide: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?32/1/32788?source=see_link\">",
"    see \"Nateglinide: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F200158\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Starlix&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F200159\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Starlix&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F200184\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antidiabetic Agent, Meglitinide Derivative",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F200162\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Management of type 2 diabetes mellitus:",
"     </b>",
"     Oral: Initial and maintenance dose: 120 mg 3 times/day, 1-30 minutes before meals; may be given alone or in combination with metformin or a thiazolidinedione; patients close to Hb A",
"     <sub>",
"      1c",
"     </sub>",
"     goal may be started at 60 mg 3 times/day",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F200163\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F200164\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No specific dosage adjustment is recommended for patients with mild-to-severe renal disease. Patients on dialysis showed reduced medication exposure and plasma protein binding. Patients with severe renal dysfunction are more susceptible to glucose-lowering effect; use with caution.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F200165\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Increased serum levels are seen with mild hepatic insufficiency; no dosage adjustment is needed. Has not been studied in patients with moderate-to-severe liver disease; use with caution.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F200129\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 60 mg, 120 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Starlix&reg;: 60 mg, 120 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F200115\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F200133\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Patients who are anorexic or NPO will need to have their dose held to avoid hypoglycemia.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F200132\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Management of type 2 diabetes mellitus (noninsulin dependent, NIDDM) as monotherapy when hyperglycemia cannot be managed by diet and exercise alone; in combination with metformin or a thiazolidinedione to lower blood glucose in patients whose hyperglycemia cannot be controlled by exercise, diet, or a single agent alone",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F5977968\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F200182\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     As reported with nateglinide monotherapy:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%: Respiratory: Upper respiratory infection (11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Dizziness (4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hypoglycemia (2%), uric acid increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea (3%), weight gain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Back pain, (4%), arthropathy (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Bronchitis (3%), cough (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Flu-like syndrome (4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Postmarketing and/or case reports: Cholestatic hepatitis, hypersensitivity reactions (including pruritus, rash, urticaria), jaundice, liver enzymes increased",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F200136\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to nateglinide or any component of the formulation; diabetic ketoacidosis, with or without coma (treat with insulin); type 1 diabetes mellitus (insulin dependent, IDDM)",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F200119\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypoglycemia: May cause hypoglycemia; appropriate patient selection, dosage, and patient education are important to avoid hypoglycemic episodes.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Adrenal/pituitary impairment: Use with caution in patients with adrenal and/or pituitary impairment; may be more susceptible to glucose-lowering effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with moderate-to-severe hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with severe renal impairment; may be more susceptible to glucose-lowering effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Stress-related states: It may be necessary to discontinue nateglinide and administer insulin if the patient is exposed to stress (ie, fever, trauma, infection, surgery).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Agents stimulating insulin release: Patients not adequately controlled on oral agents which stimulate insulin release (eg, glyburide) should not be switched to nateglinide or have nateglinide added to therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Metformin: Indicated for adjunctive therapy with metformin; not to be used as a substitute for metformin monotherapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sulfonylureas: Combination treatment with sulfonylureas is not recommended (no additional benefit).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Use with caution in the elderly; may be more susceptible to glucose-lowering effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Malnourished patients: Use with caution in malnourished patients; may be more susceptible to glucose-lowering effects.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F200178\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP2C9 (major), CYP3A4 (major), SLCO1B1;",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP2C9 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F200123\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Conivaptan: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Orally Inhaled): May diminish the hypoglycemic effect of Antidiabetic Agents. In some instances, corticosteroid-mediated HPA axis suppression has led to episodes of acute adrenal crisis, which may manifest as enhanced hypoglycemia, particularly in the setting of insulin or other antidiabetic agent use.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): May diminish the hypoglycemic effect of Antidiabetic Agents. In some instances, corticosteroid-mediated HPA axis suppression has led to episodes of acute adrenal crisis, which may manifest as enhanced hypoglycemia, particularly in the setting of insulin or other antidiabetic agent use.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C9 Inducers (Strong): May increase the metabolism of CYP2C9 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C9 Inhibitors (Moderate): May decrease the metabolism of CYP2C9 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C9 Inhibitors (Strong): May decrease the metabolism of CYP2C9 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May increase the metabolism of CYP3A4 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eltrombopag: May increase the serum concentration of OATP1B1/SLCO1B1 Substrates. Management: According to eltrombopag prescribing information, consideration of a preventative dose reduction may be warranted.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (CYP3A4 Inducers): May increase the metabolism of CYP3A4 Substrates. Management: Consider avoiding CYP3A4 inducing herbs in order to avoid therapeutic failure of the substrate. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypoglycemic Properties): May enhance the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypoglycemic Agents: May enhance the adverse/toxic effect of other Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Loop Diuretics: May diminish the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Luteinizing Hormone-Releasing Hormone Analogs: May diminish the therapeutic effect of Antidiabetic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP2C9 Substrates. Management: Use CYP2C9 substrates at the lowest recommended dose, and monitor closely for adverse effects, during and in the 2 weeks following mifepristone treatment.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP3A4 Substrates. Management: Minimize doses of CYP3A4 substrates, and monitor for increased concentrations/toxicity, during and 2 weeks following treatment with mifepristone. Avoid cyclosporine, dihydroergotamine, ergotamine, fentanyl, pimozide, quinidine, sirolimus, and tacrolimus.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2C9 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pegvisomant: May enhance the hypoglycemic effect of Antidiabetic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salicylates: May enhance the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: May enhance the hypoglycemic effect of Hypoglycemic Agents. Selective Serotonin Reuptake Inhibitors may increase the serum concentration of Hypoglycemic Agents. Management: Consider increased monitoring of glycemic control with concomitant use of a hypoglycemic agent and an SSRI. Dosage adjustments of the hypoglycemic agent may be necessary upon SSRI initiation or discontinuation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Somatropin: May diminish the hypoglycemic effect of Antidiabetic Agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: May diminish the therapeutic effect of Antidiabetic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F200154\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: Avoid ethanol (increased risk of hypoglycemia).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Food: Rate of absorption is decreased and time to T",
"     <sub>",
"      max",
"     </sub>",
"     is delayed when taken with food. Food does not affect AUC. Multiple peak plasma concentrations may be observed if fasting. Not affected by composition of meal.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Herb/Nutraceutical: Avoid alfalfa, aloe, bilberry, bitter melon, burdock, celery, damiana, fenugreek, garcinia, garlic, ginger, ginseng (American), gymnema, marshmallow, and stinging nettle (may enhance the hypoglycemic effects of antidiabetic agents). St. John's wort may decrease the levels/effect of nateglinide.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F200125\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F200140\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events have been observed in animal reproduction studies; therefore, nateglinide is classified as pregnancy category C. Information describing the effects of nateglinide on pregnancy outcomes is limited. Maternal hyperglycemia can be associated with adverse effects in the fetus, including macrosomia, neonatal hyperglycemia, and hyperbilirubinemia; the risk of congenital malformations is increased when the Hb A",
"     <sub>",
"      1c",
"     </sub>",
"     is above the normal range. Diabetes can also be associated with adverse effects in the mother. Poorly-treated diabetes may cause end-organ damage that may in turn negatively affect obstetric outcomes. Physiologic glucose levels should be maintained prior to and during pregnancy to decrease the risk of adverse events in the mother and the fetus. Until additional safety and efficacy data are obtained, the use of oral agents is generally not recommended as routine management of GDM or type 2 diabetes mellitus during pregnancy. Insulin is the drug of choice for the control of diabetes mellitus during pregnancy.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F200168\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F6209488\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     It is not known if nateglinide is excreted in breast milk. Breast-feeding is not recommended by the manufacturer.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F200141\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Nateglinide should be taken 1-30 minutes prior to meals. Scheduled dose should not be taken if meal is missed. Dietary modification based on ADA recommendations is a part of therapy. Decreases blood glucose concentration. Hypoglycemia may occur. Must be able to recognize symptoms of hypoglycemia (palpitations, sweaty palms, lightheadedness).",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F200139\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Nateglinide Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     60 mg (100): $166.22",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     120 mg (100): $172.70",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Starlix Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     60 mg (100): $258.67",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     120 mg (100): $268.74",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F200127\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Glucose and Hb A",
"     <sub>",
"      1c",
"     </sub>",
"     levels, weight, lipid profile",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F200130\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Recommendations for glycemic control in nonpregnant adults with diabetes (ADA, 2012):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hb A",
"     <sub>",
"      1c",
"     </sub>",
"     : &lt;7% (a more aggressive [&lt;6.5%] or less aggressive [&lt;8%] Hb A",
"     <sub>",
"      1c",
"     </sub>",
"     goal may be targeted based on patient-specific characteristics)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Preprandial capillary plasma glucose: 70-130 mg/dL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Peak postprandial capillary blood glucose: &lt;180 mg/dL",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F200142\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Antangping (CL);",
"     </li>",
"     <li>",
"      Fastic (JP, KP);",
"     </li>",
"     <li>",
"      Glinade (KP);",
"     </li>",
"     <li>",
"      Glinate (IN);",
"     </li>",
"     <li>",
"      Glunat (TW);",
"     </li>",
"     <li>",
"      Glytan (PK);",
"     </li>",
"     <li>",
"      Luoyu (CL);",
"     </li>",
"     <li>",
"      Naglix (TW);",
"     </li>",
"     <li>",
"      Novirep (PK);",
"     </li>",
"     <li>",
"      Starlix (AR, BE, BR, CH, CL, CN, CO, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HN, ID, IE, MT, MX, MY, NL, NO, PE, PH, PT, RU, SE, SG, SK, TR, TW, UY, VE);",
"     </li>",
"     <li>",
"      Starsis (JP);",
"     </li>",
"     <li>",
"      Trazec (AT, BE, BG, CH, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HN, IE, IT, MT, NL, NO, PL, PT, RU, SE, SK, TR)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F200118\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     A phenylalanine derivative, nonsulfonylurea hypoglycemic agent used in the management of type 2 diabetes mellitus (noninsulin dependent, NIDDM); stimulates insulin release from the pancreatic beta cells to reduce postprandial hyperglycemia; amount of insulin release is dependent upon existing glucose levels",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F200135\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Insulin secretion: ~20 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Peak effect: 1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: 4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Rapid",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: 10 L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 98%, primarily to albumin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic via hydroxylation followed by glucuronide conjugation via CYP2C9 (70%) and CYP3A4 (30%) to metabolites",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: 73%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 1.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak: &le;1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (83%, 16% as unchanged drug); feces (10%)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Diabetes Association, &ldquo;Standards of Medical Care in Diabetes Mellitus -- 2012,&rdquo;",
"      <i>",
"       Diabetes Care",
"      </i>",
"      , 2012, 35(Suppl 1):11-63.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/21/11606/abstract-text/22187469/pubmed\" id=\"22187469\" target=\"_blank\">",
"        22187469",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, \"Canadian Diabetes Association 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada,\"",
"      <i>",
"       Can J Diabetes",
"      </i>",
"      , 20078, 32(suppl 1):1-201.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Handelsman Y, Mechanick JI, Blonde L, et al, &ldquo;American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan,&rdquo;",
"      <i>",
"       Endocr Pract",
"      </i>",
"      , 2011, 17(Suppl 2):1-53.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/21/11606/abstract-text/21474420/pubmed\" id=\"21474420\" target=\"_blank\">",
"        21474420",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kirkman M, Briscoe VJ, Clark N, et al, \"Diabetes in Older Adults: A Consensus Report,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2012; doi: 10.1111/jgs.12035.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/21/11606/abstract-text/23106132/pubmed\" id=\"23106132\" target=\"_blank\">",
"        23106132",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Qaseem A, Humphrey LL, Sweet DE, et al,&ldquo;Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline from the American College of Physicians,&rdquo;",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 2012, 156(3):218-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/21/11606/abstract-text/22312141/pubmed\" id=\"22312141\" target=\"_blank\">",
"        22312141",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rodbard HW, Jellinger PS, Davidson JA, et al, &ldquo;Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology Consensus Panel on Type 2 Diabetes Mellitus: An Algorithm for Glycemic Control,&rdquo;",
"      <i>",
"       Endocr Pract",
"      </i>",
"      , 2009, 15(6):540-59.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/21/11606/abstract-text/19858063/pubmed\" id=\"19858063\" target=\"_blank\">",
"        19858063",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9927 Version 42.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-78.134.254.52-C266496ECC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_21_11606=[""].join("\n");
var outline_f11_21_11606=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200158\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200159\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200184\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200162\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200163\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200164\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200165\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200129\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200115\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200133\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200132\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5977968\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200182\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200136\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200119\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200178\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200123\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200154\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200125\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200140\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200168\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6209488\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200141\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200139\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200127\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200130\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200142\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200118\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200135\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9927\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9927|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?32/1/32788?source=related_link\">",
"      Nateglinide: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_21_11607="Carisoprodol, aspirin, and codeine: Drug information";
var content_f11_21_11607=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Carisoprodol, aspirin, and codeine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?30/42/31396?source=see_link\">",
"    see \"Carisoprodol, aspirin, and codeine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block spa drugH1Div\" id=\"F14854547\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Special Alerts",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      FDA Warns of Codeine Use in Children After Tonsillectomy and/or Adenoidectomy",
"     </span>",
"     <span class=\"collapsible-date\">",
"      August 2012",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       The FDA has issued a Drug Safety Communication after reviewing reports of children who developed serious adverse effects, including death, after receiving codeine in the usual dosage range for pain relief following tonsillectomy and/or adenoidectomy for obstructive sleep apnea syndrome. Three deaths occurred in children that had evidence of a genetic variation (&ldquo;ultrarapid metabolizers&rdquo;) which results in faster and more complete conversion of codeine to morphine, possibly leading to overdose or death. The estimated incidence of this genetic variation is ~1-7 per 100 people, but may be higher in some ethnic groups.",
"      </p>",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       Healthcare professionals should be aware of the risks associated with the administration of codeine or codeine-containing drugs in children after tonsillectomy and/or adenoidectomy for obstructive sleep apnea and should use the lowest effective dose for the least amount of time on an as-needed basis. Parents and caregivers who observe signs of overdose in a child such as unusual sleepiness, confusion, or difficult or noisy breathing should stop codeine administration and seek medical attention immediately.",
"      </p>",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       Further information may be found at",
"       <a href=\"file://www.fda.gov/Drugs/DrugSafety/ucm313631.htm#\" target=\"_blank\">",
"        file://www.fda.gov/Drugs/DrugSafety/ucm313631.htm#",
"       </a>",
"       .",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F146463\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Skeletal Muscle Relaxant",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F146454\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Skeletal muscle relaxant, analgesic: Oral: 1 or 2 tablets 4 times/day (maximum: 8 tablets/day); treatment should be temporary (2-3 weeks)",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F146455\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid or use with caution in the elderly (&gt;65 years of age); adverse effects (eg, orthostatic hypotension and CNS depression) may be potentiated.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15682506\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15682507\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F146446\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling. [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet: Carisoprodol 200 mg, aspirin 325 mg, and codeine phosphate 16 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F146436\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block csi drugH1Div\" id=\"F146465\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Controlled Substance",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C-III",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F146448\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Skeletal muscle relaxant",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F13931417\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - moderate; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F6825416\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F6825404\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to a carbamate (eg, meprobamate); serious gastrointestinal complications (eg, bleeding, perforations, obstruction) due to aspirin use; aspirin-induced asthma; acute intermittent porphyria",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F6825405\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;\">",
"     <b>",
"      Concerns related to adverse effects:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; CNS depression: May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Gastrointestinal effects: Serious GI effects (eg, bleeding, perforation, and intestinal obstruction) may occur (possibly fatal) with aspirin use. Use with caution in patients with a history of GI bleeding from ulcers; history of poor baseline health; geriatric patients; patients taking high doses of aspirin; patients taking concurrent anticoagulants, NSAIDs, or large amounts of ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Hypotension: May cause hypotension; use with caution in patients with hypovolemia, cardiovascular disease (including acute MI), or drugs which may exaggerate hypotensive effects (including phenothiazines or general anesthetics).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Phenanthrene hypersensitivity: Use with caution in patients with hypersensitivity reactions to other phenanthrene-derivative opioid agonists (hydrocodone, hydromorphone, levorphanol, oxycodone, oxymorphone).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Salicylate sensitivity: Patients with sensitivity to tartrazine dyes, nasal polyps, and asthma may have an increased risk of salicylate sensitivity.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Seizures: Carisoprodol has been associated (rarely) with seizures in patients with and without seizure history.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Disease-related concerns:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Abdominal conditions: May obscure diagnosis or clinical course of patients with acute abdominal conditions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Biliary tract impairment: Use with caution in patients with biliary tract dysfunction; acute pancreatitis may cause constriction of sphincter of Oddi.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Drug abuse: Use with caution in patients with a history of drug abuse or acute alcoholism; potential for drug dependency exists. Tolerance, psychological and physical dependence may occur with prolonged use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Head trauma: Use with extreme caution in patients with head injury, intracranial lesions, or elevated intracranial pressure; exaggerated elevation of ICP may occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment; not studied.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment; not studied.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Respiratory disease: Use with caution in patients with pre-existing respiratory compromise (hypoxia and/or hypercapnia), COPD or other obstructive pulmonary disease, and kyphoscoliosis or other skeletal disorder which may alter respiratory function; critical respiratory depression may occur, even at therapeutic dosages.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Concurrent drug therapy issues:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Sedatives: Effects may be potentiated when used with other sedative drugs or ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Special populations:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; CYP2D6 &ldquo;ultrarapid metabolizers&rdquo;: Use caution in patients with two or more copies of the variant CYP2D6*2 allele; may have extensive conversion from codeine to morphine and thus increased opioid-mediated effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Elderly: Muscle relaxants are poorly tolerated by the elderly due to potent anticholinergic effects, sedation, and risk of fracture. Efficacy is questionable at dosages tolerated by elderly patients; avoid use (Beers Criteria).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Pediatrics: Safety and efficacy have not been established in children &lt;16 years of age.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Surgical patients: Aspirin should be avoided (if possible) in surgical patients for 1-2 weeks prior to surgery, to reduce the risk of excessive bleeding.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Other warnings/precautions:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull;	Withdrawal: Concurrent use of agonist/antagonist analgesics may precipitate withdrawal symptoms and/or reduced analgesic efficacy in patients following prolonged therapy with mu opioid agonists. Abrupt discontinuation following prolonged use may also lead to withdrawal symptoms",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F146460\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to individual components.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F146441\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ACE Inhibitors: Salicylates may diminish the antihypertensive effect of ACE Inhibitors. They may also diminish other beneficial pharmacodynamic effects desired for the treatment of CHF.  The effects are likely dose-related.  100 mg doses aspirin appear to cause no problems, whereas 300 mg doses appear to significantly affect ACE Inhibitor efficacy.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Agents with Antiplatelet Properties (e.g., P2Y12 inhibitors, NSAIDs, SSRIs, etc.): May enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alendronate: Aspirin may enhance the adverse/toxic effect of Alendronate. Specifically gastrointestinal adverse events.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alvimopan: Analgesics (Opioid) may enhance the adverse/toxic effect of Alvimopan. This is most notable for patients receiving long-term (i.e., more than 7 days) opiates prior to alvimopan initiation.  Management: Alvimopan is contraindicated in patients receiving therapeutic doses of opioids for more than 7 consecutive days immediately prior to alvimopan initiation.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ammonium Chloride: May increase the serum concentration of Salicylates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ammonium Chloride: May increase the excretion of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: May enhance the analgesic effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticoagulants: Salicylates may enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antidepressants (Tricyclic, Tertiary Amine): May enhance the antiplatelet effect of Aspirin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotic Agents (Phenothiazines): May enhance the hypotensive effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers (Nondihydropyridine): May enhance the anticoagulant effect of Salicylates.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Bepridil [Off Market].",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Carbonic Anhydrase Inhibitors: Salicylates may enhance the adverse/toxic effect of Carbonic Anhydrase Inhibitors. Salicylate toxicity might be enhanced by this same combination.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Brinzolamide; Dorzolamide.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Collagenase (Systemic): Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Collagenase (Systemic). Specifically, the risk of injection site bruising and/or bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): Salicylates may enhance the adverse/toxic effect of Corticosteroids (Systemic). These specifically include gastrointestinal ulceration and bleeding. Corticosteroids (Systemic) may decrease the serum concentration of Salicylates. Withdrawal of corticosteroids may result in salicylate toxicity.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C19 Inducers (Strong): May increase the metabolism of CYP2C19 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C19 Inhibitors (Moderate): May decrease the metabolism of CYP2C19 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C19 Inhibitors (Strong): May decrease the metabolism of CYP2C19 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Inhibitors (Moderate): May diminish the therapeutic effect of Codeine. These CYP2D6 inhibitors may prevent the metabolic conversion of codeine to its active metabolite morphine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Inhibitors (Strong): May diminish the therapeutic effect of Codeine. These CYP2D6 inhibitors may prevent the metabolic conversion of codeine to its active metabolite morphine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dabigatran Etexilate: Agents with Antiplatelet Properties may enhance the anticoagulant effect of Dabigatran Etexilate. Agents with Antiplatelet Properties may increase the serum concentration of Dabigatran Etexilate. This mechanism applies specifically to clopidogrel.  Management: Increase monitoring for signs/symptoms of bleeding. The Canadian product monograph for dabigatran specifically recommends avoiding concomitant use with GIIb/IIIa inhibitors or ticlopidine, or with aspirin used for stroke prevention in atrial fibrillation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May enhance the anticoagulant effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Desmopressin: Analgesics (Opioid) may enhance the adverse/toxic effect of Desmopressin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Divalproex: Salicylates may increase the serum concentration of Divalproex.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Drotrecogin Alfa (Activated): Salicylates may enhance the adverse/toxic effect of Drotrecogin Alfa (Activated). Bleeding may occur.  Management: Weigh potential benefits of drotrecogin against increased bleeding risk in patients who have received  platelet inhibitors including aspirin (over 650 mg daily within 1 week). Monitor for bleeding and stop infusion if clinically important bleeding occurs.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Floctafenine: May enhance the adverse/toxic effect of Aspirin. An increased risk of bleeding may be associated with use of this combination. Floctafenine may diminish the cardioprotective effect of Aspirin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ginkgo Biloba: May enhance the anticoagulant effect of Salicylates. Management: Consider alternatives to this combination of agents. Monitor for signs and symptoms of bleeding (especially intracranial bleeding) if salicylates are used in combination with ginkgo biloba.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Glucosamine: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Heparin: Aspirin may enhance the anticoagulant effect of Heparin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Anticoagulant/Antiplatelet Properties) (eg, Alfalfa, Anise, Bilberry): May enhance the adverse/toxic effect of Salicylates. Bleeding may occur.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: Salicylates may diminish the therapeutic effect of Hyaluronidase.  Management: Patients receiving salicylates (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase.  Larger doses of hyaluronidase may be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypoglycemic Agents: Salicylates may enhance the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ibritumomab: Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Ibritumomab. Both agents may contribute to impaired platelet function and an increased risk of bleeding.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Influenza Virus Vaccine (Live/Attenuated): May enhance the adverse/toxic effect of Salicylates. Specifically, Reye's syndrome may develop.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketorolac (Nasal): May enhance the adverse/toxic effect of Aspirin. An increased risk of bleeding may be associated with use of this combination. Ketorolac (Nasal) may diminish the cardioprotective effect of Aspirin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketorolac (Systemic): May enhance the adverse/toxic effect of Aspirin. An increased risk of bleeding may be associated with use of this combination. Ketorolac (Systemic) may diminish the cardioprotective effect of Aspirin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Loop Diuretics: Salicylates may diminish the diuretic effect of Loop Diuretics. Loop Diuretics may increase the serum concentration of Salicylates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrexate: Salicylates may increase the serum concentration of Methotrexate. Salicylate doses used for prophylaxis of cardiovascular events are not likely to be of concern.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mixed Agonist / Antagonist Opioids: May diminish the analgesic effect of Analgesics (Opioid). Management: Seek alternatives to mixed agonist/antagonist opioids in patients receiving pure opioid agonists, and monitor for symptoms of therapeutic failure/high dose requirements (or withdrawal in opioid-dependent patients) if patients receive these combinations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): May enhance the antiplatelet effect of Aspirin. Aspirin may decrease the serum concentration of Multivitamins/Minerals (with ADEK, Folate, Iron). Specifically, aspirin may decrease absorption of ascorbic acid.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     NSAID (COX-2 Inhibitor): Aspirin may enhance the adverse/toxic effect of NSAID (COX-2 Inhibitor).  Management: Concurrent use of aspirin at doses beyond cardioprotective levels is not recommended.  While concurrent use of low-dose aspirin with a COX-2 inhibitor is permissable, patients should be monitored closely for signs/symptoms of GI ulceration/bleeding.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     NSAID (Nonselective): May enhance the adverse/toxic effect of Salicylates. An increased risk of bleeding may be associated with use of this combination. NSAID (Nonselective) may diminish the cardioprotective effect of Salicylates. Salicylates may decrease the serum concentration of NSAID (Nonselective).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Omacetaxine: Aspirin may enhance the adverse/toxic effect of Omacetaxine. Specifically, the risk for bleeding-related events may be increased.  Management: Avoid concurrent use of aspirin with omacetaxine in patients with a platelet count of less than 50,000/uL.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Omega-3 Fatty Acids: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pegvisomant: Analgesics (Opioid) may diminish the therapeutic effect of Pegvisomant.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentosan Polysulfate Sodium: May enhance the adverse/toxic effect of Agents with Antiplatelet Properties. Specifically, the risk of bleeding may be increased by concurrent use of these agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentoxifylline: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Potassium Acid Phosphate: May increase the serum concentration of Salicylates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     PRALAtrexate: Salicylates may increase the serum concentration of PRALAtrexate. Salicylate doses used for prophylaxis of cardiovascular events are unlikely to be of concern.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Probenecid: Salicylates may diminish the therapeutic effect of Probenecid.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prostacyclin Analogues: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rivaroxaban: Agents with Antiplatelet Properties may enhance the anticoagulant effect of Rivaroxaban.  Management: Avoid concurrent use of clopidogrel with rivaroxaban unless the anticipated benefits outweigh the risks of bleeding.  Avoid concurrent use of rivaroxaban with other antiplatelet agents whenever possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salicylates: May enhance the anticoagulant effect of other Salicylates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: Analgesics (Opioid) may enhance the serotonergic effect of Selective Serotonin Reuptake Inhibitors. This may cause serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: May enhance the antiplatelet effect of Aspirin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin/Norepinephrine Reuptake Inhibitors: May enhance the antiplatelet effect of Aspirin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Somatostatin Analogs: May decrease the metabolism of Codeine. The formation of two major codeine metabolites (morphine and norcodeine) may be impaired by somatostatin analogs.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Succinylcholine: May enhance the bradycardic effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: Analgesics (Opioid) may enhance the orthostatic hypotensive effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thrombolytic Agents: Salicylates may enhance the adverse/toxic effect of Thrombolytic Agents. An increased risk of bleeding may occur.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ticagrelor: Aspirin may enhance the antiplatelet effect of Ticagrelor. Aspirin may diminish the therapeutic effect of Ticagrelor. More specifically, the benefits of ticagrelor relative to clopidogrel may be diminished in patients receiving daily aspirin doses greater than 100-150 mg daily.  Management: Avoid daily aspirin doses greater than 100 mg in patients receiving ticagrelor.  Canadian recommendations are to avoid daily aspirin doses greater than 150 mg.  Daily low-dose aspirin (U.S.: 75-100 mg; Canada: 75-150 mg) is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiludronate: Aspirin may decrease the serum concentration of Tiludronate.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tipranavir: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tositumomab and Iodine I 131 Tositumomab: Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Tositumomab and Iodine I 131 Tositumomab. Specifically, the risk of bleeding-related adverse events may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Treprostinil: May enhance the adverse/toxic effect of Salicylates. Bleeding may occur.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Valproic Acid: Salicylates may increase the serum concentration of Valproic Acid.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Varicella Virus-Containing Vaccines: Salicylates may enhance the adverse/toxic effect of Varicella Virus-Containing Vaccines. Reye's Syndrome may develop.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin E: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Salicylates may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F146452\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herb/Nutraceutical: St John's wort may decrease codeine levels. Avoid valerian, St John's wort, kava kava, gotu kola (may increase CNS depression). Avoid cat's claw, dong quai, evening primrose, feverfew, garlic, ginger, ginkgo, red clover, horse chestnut, green tea, ginseng (all have additional antiplatelet activity). Limit curry powder, paprika, licorice; may cause salicylate accumulation (these foods contain 6 mg salicylate/100 g; an ordinary American diet contains 10-200 mg/day of salicylate).",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F146442\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F14287194\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted with this combination. Refer to individual monographs.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F146457\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F6825403\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Carisoprodol, aspirin, and codeine are excreted into breast milk. Refer to individual monographs for additional information.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F2524402\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Carisoprodol-Aspirin-Codeine Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     200-325-16 mg (100): $277.50",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F6825420\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F146450\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Geriatrics Society 2012 Beers Criteria Update Expert Panel, \"American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2012, 60(4):616-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?11/21/11607/abstract-text/22376048/pubmed\" id=\"22376048\" target=\"_blank\">",
"        22376048",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8679 Version 44.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-118.195.65.247-9CA6F9C4F1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_21_11607=[""].join("\n");
var outline_f11_21_11607=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14854547\">",
"      Special Alerts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146463\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146454\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146455\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15682506\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15682507\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146446\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146436\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146465\">",
"      Controlled Substance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146448\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13931417\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6825416\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6825404\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6825405\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146460\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146441\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146452\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146442\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14287194\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146457\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6825403\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2524402\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6825420\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146450\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8679\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8679|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?30/42/31396?source=related_link\">",
"      Carisoprodol, aspirin, and codeine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_21_11608="Differential diagnosis of a neck mass";
var content_f11_21_11608=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Differential diagnosis of a neck mass",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/21/11608/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/21/11608/contributors\">",
"     Kevin Emerick, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/21/11608/contributors\">",
"     Derrick Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/21/11608/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/21/11608/contributors\">",
"     Daniel G Deschler, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/21/11608/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/21/11608/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/21/11608/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 13, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of a mass in the neck is broad, extensive, and includes both serious and benign etiologies. Accurate diagnosis of a neck mass is critical.",
"   </p>",
"   <p>",
"    It is helpful to consider the differential diagnosis in three broad categories:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Congenital",
"     </li>",
"     <li>",
"      Inflammatory",
"     </li>",
"     <li>",
"      Neoplastic",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The patient's history and physical examination will often allow designation of the neck mass into one of these three categories. However, particularly in adult patients, the potential for malignancy in any neck mass should be adequately excluded before a benign diagnosis is established.",
"   </p>",
"   <p>",
"    This topic aims to present a framework for the differential diagnosis of a mass in the neck. Approach to patient evaluation is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/24/7558?source=see_link\">",
"     \"Evaluation of a neck mass\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ANATOMY OF THE NECK AND LYMPH NODE DRAINAGE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The location of the mass can focus the differential [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11608/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Familiarity with neck anatomy is critical for diagnosis and management of disease processes affecting this region. The neck is traditionally divided into the central and the lateral necks, with the lateral neck further subdivided into anterior and posterior triangles (",
"    <a class=\"graphic graphic_figure graphicRef74489 \" href=\"UTD.htm?41/25/42388\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Additionally, patterns of lymph node drainage can identify areas of concern when metastatic disease is suspected. The localization of lymph nodes in the neck is shown in a figure (",
"    <a class=\"graphic graphic_figure graphicRef69528 \" href=\"UTD.htm?18/53/19285\">",
"     figure 2",
"    </a>",
"    ), and patterns of lymphatic drainage are shown in a table (",
"    <a class=\"graphic graphic_table graphicRef77551 \" href=\"UTD.htm?30/62/31723\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CONGENITAL NECK MASS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital neck masses are usually present at birth, but may present at any age. They are the most common noninflammatory neck mass in children. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/59/1977?source=see_link\">",
"     \"Congenital anomalies of the jaw, mouth, oral cavity, and pharynx\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For masses presenting in adulthood, the patient should be approached with a presumption of malignancy until proven otherwise. Although cystic lesions such as branchial cleft cysts can present in adulthood, these lesions should be approached with a keen diagnostic eye to ensure malignancy is not present. Carcinomas of the tonsil, tongue base, and thyroid may all present as cystic neck masses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Branchial cleft cyst",
"    </span>",
"    &nbsp;&mdash;&nbsp;Branchial cleft cysts account for almost 20 percent of pediatric neck masses [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11608/abstract/3\">",
"     3",
"    </a>",
"    ]. They usually present in late childhood or early adulthood when a previously unrecognized cyst becomes infected. Only a very small percentage first present in adulthood. The cysts are relatively consistent in their location in the neck, anterior to the sternocleidomastoid muscle. Branchial cleft cysts are further subdivided based on the developmental origin (",
"    <a class=\"graphic graphic_figure graphicRef81013 \" href=\"UTD.htm?25/23/25972\">",
"     figure 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    First branchial cleft cysts account for less than 1 percent of branchial cleft anomalies. They typically appear on the face near the auricle. First branchial cleft cysts are further divided into types I and II [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11608/abstract/1\">",
"     1",
"    </a>",
"    ]. Type I first branchial cleft cysts are duplication anomalies of the external auditory canal and are of ectodermal origin. They pass through the parotid gland often in close proximity to the facial nerve. Type II branchial cleft cysts are more common and typically present below the angle of the mandible. They contain both ectoderm and mesoderm and pass through the parotid gland medial or lateral to the facial nerve and end either inferior to the external auditory canal or at the bony cartilaginous junction of the external auditory canal.",
"   </p>",
"   <p>",
"    Second branchial cleft cysts are the most common type of branchial cleft anomaly. They are usually located just inferior to the angle of the mandible and anterior to the sternocleidomastoid muscle. The sinus tract of a second branchial cleft cyst will travel through the deep structures of the neck and open into the tonsillar fossa.",
"   </p>",
"   <p>",
"    Third branchial cleft cysts also are located anterior to the sternocleidomastoid muscle but are typically lower in the neck than a second branchial cleft cyst. These anomalies end in the pharynx at the thyrohyoid membrane or pyriform sinus.",
"   </p>",
"   <p>",
"    Recurrent infections of branchial cysts can occur, and a fistula tract to the skin may develop. Recurrent infections may complicate surgical removal, increasing the risk of injury to important structures such as the facial nerve when the parotid is involved. Acute severe infections of third or fourth branchial cleft cysts can cause pharyngeal edema and airway and swallowing problems. Management of branchial cleft cysts begins with controlling infection, if present. Once the infection has resolved, the mass is usually excised to prevent future problems [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11608/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Thyroglossal duct cyst",
"    </span>",
"    &nbsp;&mdash;&nbsp;In contrast to branchial cleft cysts, thyroglossal duct cysts present as a midline mass in the anterior neck. They are often asymptomatic until they become infected in the setting of an upper respiratory tract infection. Thyroglossal duct cysts are usually diagnosed in childhood, but up to 40 percent may present after age 20 [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11608/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/16/25864?source=see_link\">",
"     \"Thyroglossal duct cysts and ectopic thyroid\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Surgical treatment is the standard in the management of thyroglossal duct cysts. The Sistrunk operation is the procedure of choice. It includes excision of the cyst as well as the tract which often passes through the central portion of the hyoid bone to the base of tongue. Since thyroid carcinoma can be present in a small percentage (1 to 2 percent) of thyroglossal duct cysts, all thyroglossal duct cysts and tracts should undergo a careful histologic examination [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11608/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Vascular anomalies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vascular anomalies can be considered as two groups: vascular tumors and vascular malformations. Both types of anomalies can present as a neck mass [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11608/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/21/30038?source=see_link\">",
"     \"Vascular lesions in the newborn\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Vascular tumors are endothelial neoplasms characterized by increased cellular proliferation. The most common type is a hemangioma, although rare tumors (eg, hemangiopericytoma, hemangioendothelioma, and angiosarcoma) may also occur.",
"   </p>",
"   <p>",
"    Hemangiomas occur almost exclusively in infants and have a characteristic rapid growth phase followed by a slow regression. Typically, overlying skin changes will suggest this diagnosis. Hemangiomas often appear as a compressible red or bluish soft mass. An associated bruit may be present on auscultation. A full physical exam should be performed since a second hemangioma may be present in the subglottis, gastrointestinal tract, or spine. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/23/5495?source=see_link\">",
"     \"Evaluation and diagnosis of infantile hemangiomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Management of hemangiomas consists initially of watchful waiting, since the majority will resolve spontaneously and the benign tumor will not recur. Intervention is necessary when the lesion is symptomatic (eg, airway compromise or bleeding). Systemic glucocorticoids or surgical laser excision are the treatment options in this setting. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/60/25546?source=see_link\">",
"     \"Management of infantile hemangiomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Vascular malformations describe a group of anomalies arising from errors of embryonic and fetal development. The classification is based on the clinical, radiographic, and histologic appearance of abnormal channels. These channels can be arterial, venous, lymphatic, or a combination. Lymphatic malformations are the most likely to present as a neck mass. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/21/30038?source=see_link\">",
"     \"Vascular lesions in the newborn\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    On physical examination, these masses are typically soft, nontender, and compressible. The overlying skin is usually normal and the mass can be transilluminated.",
"   </p>",
"   <p>",
"    Treatment is directed at preventing recurrent bleeding or infection, correcting contour deformity, and improving function. Surgery is the main treatment modality for masses causing distortion or aerodigestive tract obstruction. Complete excision can be very difficult and may require staged procedures. Sclerotherapy has shown some benefit for macrocystic lesions. Laser treatments and coblation may have some benefit in debulking and contouring procedures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Laryngocele",
"    </span>",
"    &nbsp;&mdash;&nbsp;A laryngocele is a herniation of the saccule of the larynx. The herniation can be limited to the anatomic boundaries of the larynx (internal laryngocele), or extend through the thyrohyoid membrane (external or mixed laryngocele). When it extends beyond the larynx it often presents as an air filled cyst in the anterior neck. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/42/37543?source=see_link\">",
"     \"Congenital anomalies of the larynx\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients most often present with hoarseness, cough, and a foreign body sensation. Laryngoscopy often will demonstrate a smooth dilation at the level of the false cord, involving both the false cord and aryepiglottic fold.",
"   </p>",
"   <p>",
"    Management of a laryngocele is primarily surgical. Laryngoscopic decompression may be performed for small lesions, whereas external approaches are necessary for larger lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11608/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Ranula",
"    </span>",
"    &nbsp;&mdash;&nbsp;A ranula is a mucocele or retention cyst arising from an obstruction in the sublingual glands in the floor of mouth. The obstructed sublingual gland leads to pseudocyst formation due to mucous extravasation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/59/1977?source=see_link\">",
"     \"Congenital anomalies of the jaw, mouth, oral cavity, and pharynx\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Ranulas are often painless and slow-growing. They are most often located in the submentum. When they extend through the mylohyoid muscle into the neck they are referred to as \"plunging ranula\". Ranulas are managed by surgical resection of the mucocele with the sublingual gland [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11608/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Teratoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Teratomas arise from pluripotential cells and contain all three germ layers. They are classically large, encapsulated, and contain a cystic component. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/59/1977?source=see_link\">",
"     \"Congenital anomalies of the jaw, mouth, oral cavity, and pharynx\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Teratomas typically arise in the first year of life and can cause significant aerodigestive obstruction. Surgical excision is recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11608/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Dermoid cyst",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dermoid cysts are due to entrapment of epithelium in deeper tissue, occurring either developmentally or posttrauma. Congenital lesions are usually midline, nontender, mobile, submental neck masses. They are treated by surgical excision.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Thymic cyst",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thymic cysts result from implantation of thymic tissue during its embryologic descent. As a result, they often present in a midline position. However, they can present anywhere between the angle of the mandible and the midline of the neck. Thymic cysts are managed with surgical excision. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/40/32392?source=see_link\">",
"     \"Anterior mediastinal mass lesions\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     INFLAMMATORY NECK MASS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inflammatory masses are typically related to enlarged lymph nodes. Lymph node enlargement can result from infectious processes as well as inflammatory, non-infectious illnesses. An overview of causes of peripheral lymphadenopathy is shown in a table (",
"    <a class=\"graphic graphic_table graphicRef77382 \" href=\"UTD.htm?24/2/24620\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/10/39080?source=see_link\">",
"     \"Evaluation of peripheral lymphadenopathy in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/27/8632?source=see_link&amp;anchor=H5#H5\">",
"     \"Etiology and clinical manifestations of cervical lymphadenitis in children\", section on 'Overview'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Infectious inflammatory disorders",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Reactive viral lymphadenopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reactive viral lymphadenopathy is the most common cause of cervical lymphadenopathy, especially in children. Typically, viral lymphadenopathy arises in the setting of routine upper respiratory infections caused by adenovirus, rhinovirus, or enterovirus. Epstein Barr Virus causes infectious mononucleosis and has a unique course.",
"   </p>",
"   <p>",
"    Typical viral infections cause symptoms for one to two weeks; lymphadenopathy generally resolves within one to two weeks of symptom resolution. The lymphadenopathy is typically tender and located in the submandibular region or jugular chain. Fixed firm lymphadenopathy is particularly concerning for noninfectious lymphadenopathy and should lead to referral for imaging and biopsy. Lymphadenopathy greater than 1 cm in size that persists for more than two weeks after resolution of other viral symptoms is concerning and should be evaluated with imaging. CT findings of lymph nodes less than 1 cm (or 1.5 cm in the upper jugulodigastric chain), oblong in shape, with no evidence of central hypodensity, and a preserved vascular hilum are reassuring features. Lymphadenopathy that appears benign should be closely followed; failure to improve in the following weeks requires additional workup including possible biopsy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    serologic testing for chronic infectious or inflammatory disorders.",
"   </p>",
"   <p>",
"    Lymphadenopathy attributable to mononucleosis is often associated with neck nodes that are quite large (&gt;2 cm) and may also occur in the posterior triangle. Typically there is accompanying axillary and inguinal lymphadenopathy as well as tonsillar hypertrophy. Mononucleosis has a characteristic prodrome of fatigue, malaise, fever, and severe pharyngitis. This lymphadenopathy may routinely take four to six weeks to resolve. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31018?source=see_link\">",
"     \"Infectious mononucleosis in adults and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Bacterial lymphadenopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Suppurative lymphadenopathy results from a bacterial infection, typically in the pharynx or skin, that causes suppuration within the enlarged lymph nodes. The most common organisms are Staphylococcus aureus and group A beta-Streptococcus. Patients should be treated initially with antibiotic therapy directed at these organisms. MRSA is an increasing problem, but is still low in incidence as a cause of suppurative lymphadenopathy. MRSA should be considered in patients who have been recently hospitalized, have an occupational exposure. Patients with a poor response to initial antibiotic therapy may require needle aspiration or incision and drainage of the abscess, with subsequent culture for bacterial diagnosis.",
"   </p>",
"   <p>",
"    A few specific bacteria merit individual mention. &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tularemia is caused by Francisella tularensis. Transmission via rabbits is best known, but it can also be passed by ticks or contaminated water. Patients commonly present with",
"      <span class=\"nowrap\">",
"       tonsillitis/pharyngitis",
"      </span>",
"      as well as painful lymphadenopathy. Systemic symptoms of fever, chills, fatigue, and headache are common. Throat culture and serologic testing confirm the diagnosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/10/30888?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and treatment of tularemia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Brucellosis (also called undulant, Mediterranean, or Malta fever) is caused by one of four species of Brucella, a gram negative organism, and can be acquired from one of several farm animals by direct contact or by eating the butter or milk from one of these animals. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/43/16058?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and treatment of brucellosis\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Cows, pigs, goats, elk and bison are all known to be potential carriers. A constellation of symptoms including generalized weakness, sweating, chills, malaise, headache, backache, and arthralgia typically occur. Afternoon fever peaks are part of the classic presentation.",
"     </li>",
"     <li>",
"      Cat-scratch disease usually presents with submandibular",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      preauricular lymphadenopathy. Cat-scratch disease is caused by Rochalimaea henselae, which is carried by felines. An exposure to cats can nearly always be elicited to aid in the diagnosis. Lymphadenopathy is often quite painful and accompanied by fevers and generalized malaise. Despite the discomfort the disease is usually self-limiting and requires only supportive treatment. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/47/23289?source=see_link\">",
"       \"Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/2/37925?source=see_link\">",
"       \"Treatment of cat scratch disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Actinomycosis commonly presents in the submandibular region and can be associated with dental procedures. Often the mass is painless and fluctuant. Confirmation of the diagnosis requires biopsy, which demonstrates granulomas with sulfur granules. Penicillin is the first line treatment. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21559?source=see_link\">",
"       \"Cervicofacial actinomycosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Mycobacterial infections present in a variety of forms. Tuberculosis is caused by Mycobacterium tuberculosis. The lymphadenopathy is classically diffuse and commonly is bilateral. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/7/27768?source=see_link\">",
"       \"Tuberculous lymphadenitis\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Unlike tuberculosis, atypical mycobacteria is more common among the pediatric population and usually presents as a unilateral mass in the parotid or anterior neck. The overlying skin commonly becomes brawny and can appear as a hue of purple, which is almost pathognomonic. Skin testing is usually only weakly positive, so often core needle or excision is needed to obtain tissue for culture in order to confirm the diagnosis. If a focal node is the limit of the disease, surgical excision can be considered as definitive treatment. More extensive disease may be better treated with incision and curettage and antibiotics. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/17/24857?source=see_link\">",
"       \"Diagnostic approach to and initial treatment of cervical lymphadenitis in children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/42/13994?source=see_link\">",
"       \"Overview of nontuberculous mycobacterial lymphadenitis in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      HIV associated lymphadenopathy is very common, present in up to 45 percent of patients with HIV infection [",
"      <a class=\"abstract\" href=\"UTD.htm?11/21/11608/abstract/9\">",
"       9",
"      </a>",
"      ]. Adenopathy is typically caused by idiopathic hyperplasia. However, it is important to consider possible other infectious or malignant etiologies such as Mycobacterium tuberculosis, Pneumocystis carinii, lymphoma, and Kaposi sarcoma. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/2/13353?source=see_link\">",
"       \"The stages and natural history of HIV infection\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19037800\">",
"    <span class=\"h3\">",
"     Parasitic lymphadenopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Toxoplasma gondii, a protozoan parasite, is typically acquired through ingestion of inadequately cooked meat or the ingestion of cat feces. These patients often have a prolonged course of fever, malaise, myalgias, sore throat, and cervical lymphadenopathy that can be present for weeks. Other complications such as intracranial abscesses may be present. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/38/16999?source=see_link\">",
"     \"Toxoplasmosis in immunocompetent hosts\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Noninfectious inflammatory disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Noninfectious inflammatory conditions are less common than the other etiologies of lymphadenopathy. However, it is important to consider these disorders, which are often difficult to diagnose and require a thorough work up. Conditions to be considered, especially when symptoms and signs involve areas other than head and neck, include sarcoidosis, Castleman disease, Rosai-Dorfman disease, and Kawasaki disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/10/39080?source=see_link\">",
"     \"Evaluation of peripheral lymphadenopathy in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/51/6970?source=see_link\">",
"     \"Castleman's disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12248?source=see_link\">",
"     \"Kawasaki disease: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/1/30744?source=see_link&amp;anchor=H19#H19\">",
"     \"Causes of peripheral lymphadenopathy in children\", section on 'Uncommon but important causes'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     NEOPLASTIC DISORDERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both benign and malignant neoplasm can present in the neck, as noted above. The adult patient should be approached with a presumption of malignancy until proven otherwise. Carcinomas of the tonsil, tongue base, and thyroid may all present as cystic neck masses and may be initially misdiagnosed as benign disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/44/30407?source=see_link\">",
"     \"Overview of head and neck cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Metastatic head and neck carcinoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neck masses that result from metastatic disease are predominantly related to metastatic squamous cell carcinoma arising from the aerodigestive tract [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11608/abstract/10\">",
"     10",
"    </a>",
"    ]. This diagnosis should be at the forefront of the differential diagnosis for an adult with a new onset neck mass.",
"   </p>",
"   <p>",
"    Despite malignancy, these masses are usually asymptomatic. Symptoms related to the primary site of the tumor, however, can often be elicited. Diagnosis is confirmed with fine needle aspiration. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/44/30407?source=see_link\">",
"     \"Overview of head and neck cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Once the diagnosis of metastatic squamous cell carcinoma is made, a search for the primary tumor must be performed. The probable primary site can often be identified by history and physical examination; panendoscopy and directed imaging may be required.",
"   </p>",
"   <p>",
"    There is a consistent lymphatic drainage pattern for the mucosa of the aerodigestive tract (",
"    <a class=\"graphic graphic_table graphicRef77551 \" href=\"UTD.htm?30/62/31723\">",
"     table 1",
"    </a>",
"    ). Therefore, the location of the mass may provide some guidance as to the location of the primary tumor. Metastatic nodes in the posterior triangle are often related to nasopharyngeal carcinoma, whereas nodes along the upper jugular chain drain from the oral cavity, oropharynx, and larynx. Isolated supraclavicular nodes should raise concern or a tracheobronchial, distal esophageal, or stomach carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11608/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While the overwhelming majority of metastatic carcinomas are squamous cell arising from the aerodigestive tract, other primary cancers should be kept in the differential. Cutaneous malignancies of the face and scalp are becoming more common. Melanoma and aggressive squamous cell carcinomas, as well as rarer cutaneous malignancies such as Merkel cell, can metastasize to the neck.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Thyroid masses",
"    </span>",
"    &nbsp;&mdash;&nbsp;A primary thyroid tumor will usually present as a mass in the anterior neck. While the majority of these masses represent benign thyroid nodules and cysts, malignancy must be considered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28506?source=see_link\">",
"     \"Diagnostic approach to and treatment of thyroid nodules\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/15/37111?source=see_link\">",
"     \"Cystic thyroid nodules\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A thorough work up of these lesions including ultrasound and fine needle biopsy will dictate the course of treatment based on the risk or presence of malignancy. Symptoms of hoarseness or a history of radiation exposure in the setting of a new thyroid mass should increase the suspicion for malignancy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11608/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Salivary gland neoplasm",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 80 percent of salivary neoplasms arise in the parotid gland. Eighty percent of parotid tumors are benign, most commonly pleomorphic adenoma [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11608/abstract/13\">",
"     13",
"    </a>",
"    ]. The incidence of malignancy in tumors of the submandibular gland is much higher, approaching 50 percent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/44/9927?source=see_link\">",
"     \"Salivary gland tumors: Epidemiology, diagnosis, evaluation, and staging\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are several subtypes of benign salivary neoplasm, including pleomorphic adenoma, Warthin's tumor, lymphoepithelioma, oncocytoma, and monomorphic adenoma. Pleomorphic adenomas comprise approximately 80 to 85 percent of these benign tumors.",
"   </p>",
"   <p>",
"    There is a large spectrum of malignant histologies as well, including mucoepidermoid carcinoma, adenoid cystic carcinoma, varieties of adenocarcinomas, salivary duct carcinoma, squamous cell carcinoma, and carcinoma ex pleomorphic adenoma.",
"   </p>",
"   <p>",
"    Benign tumors classically present as asymptomatic enlarging masses. Signs or symptoms such as pain, cranial nerve deficits, or overlying skin changes usually herald the presence of malignancy. CT, MRI, and fine needle biopsy (FNA) all have roles in the diagnosis and evaluation of these tumors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Paragangliomas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Paragangliomas of the carotid body (previously called chemodectomas) and jugulotympanic paraganglia (previously called glomus jugulare and glomus tympanicum tumors) are highly vascular, typically benign tumors that can present as a neck mass. Paragangliomas are neoplasms that arise from extraadrenal chromaffin cells of the sympathetic and parasympathetic paraganglia; in the neck, paragangliomas arise almost exclusively from the parasympathetic paraganglia. Within the head and neck, carotid body tumors are the most common followed by jugulotympanic glomus tumors. Carotid body tumors are often pulsatile and a bruit can be heard on auscultation. Classically they are described as being mobile in a side to side direction but not in a vertical direction (the so-called positive Fontaine&rsquo;s sign). Approximately one-third are inherited as part of a genetic syndrome, and genetic screening is advised for all patients because of the implications for malignant behavior and multifocality. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/13/21720?source=see_link\">",
"     \"Paragangliomas of the head and neck\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Up to 10 percent of patients have a family history. Specific genes have been identified that help predict risk of malignancy or future development for family members [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11608/abstract/14\">",
"     14",
"    </a>",
"    ]. Ten to 20 percent of paragangliomas are multicentric. While generally considered benign histologically, up to 10 percent demonstrate malignant features and clinical course.",
"   </p>",
"   <p>",
"    Diagnosis is usually made based on characteristic features demonstrated on",
"    <span class=\"nowrap\">",
"     MRI/MRA",
"    </span>",
"    imaging. Treatment is typically surgical excision. Radiation may be considered as a means of limiting or preventing tumor growth for those tumors that may cause significant morbidity such as skull base paragangliomas involving multiple cranial nerves [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11608/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Schwannoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Schwannomas result from neoplastic proliferation of Schwann cells and generally occur as growths that are closely associated with, but relatively circumscribed from, peripheral nerves. Schwannomas can arise from any peripheral nerve; in the neck, they most often arise from the vagus nerve or superior cervical sympathetic chain.",
"   </p>",
"   <p>",
"    Schwannoma can have an insidious onset as a slow growing mass, but may also present with neurologic deficits. Vagal schwannomas may cause hoarseness or aspiration when they occur below the skull base. Sympathetic chain tumors often present with a Horner's syndrome.",
"   </p>",
"   <p>",
"    The diagnosis of a Schwannoma is made with imaging. CT scanning may not reliably distinguish a carotid body tumor from a Schwannoma, although lack of flow voids with contrast enhancement suggests schwannoma.",
"    <span class=\"nowrap\">",
"     MRI/MRA",
"    </span>",
"    or angiography is commonly indicated to establish the diagnosis.",
"   </p>",
"   <p>",
"    Expectant surgical excision for Schwannomas is often the best strategy, in the absence of neural deficit. When vagal injury or Horner's syndrome is already present, surgical therapy is indicated to prevent further growth and injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Lymphoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lymphoma can present in the head and neck. Neck involvement is very common in children with Hodgkin disease (HD), found in up to 80 percent of patients. HD should be suspected, especially in young patients with a history of fever, night sweats, chills, and diffuse lymphadenopathy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27610?source=see_link\">",
"     \"Clinical presentation and diagnosis of non-Hodgkin lymphoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/33/29206?source=see_link\">",
"     \"Initial evaluation and diagnosis of Hodgkin lymphoma in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/6/32874?source=see_link\">",
"     \"Overview of Hodgkin lymphoma in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Fine needle aspiration can help establish the diagnosis; however more tissue is typically required to perform adequate histologic classification to optimize the treatment regimen [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11608/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Lipoma and benign skin cysts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lipomas are benign neoplasms comprised of fat and are typically asymptomatic. They present as soft and ill-defined slowly enlarging masses and can occur in any location on the neck.",
"   </p>",
"   <p>",
"    Surgical excision is recommended if the mass causes functional or cosmetic problems. Pain, rapid growth, or radiographic abnormality may suggest the presence of liposarcoma and should prompt excision to rule out this aggressive lesion.",
"   </p>",
"   <p>",
"    Benign skin cysts such as epidermoid inclusion cysts, dermoids, or pilomatrixoma can also present as neck masses. They are traditionally treated with wide local excision to prevent infections and drainage in the neck.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The differential diagnosis of neck masses can be considered in three categories: congenital, inflammatory, and neoplastic. The adult patient should be approached with a presumption of malignancy until proven otherwise. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Congenital neck masses are usually present at birth, but may present at any age and are the most common noninflammatory neck mass in children. Branchial cleft cysts usually present in late childhood or early adulthood when a cyst becomes infected. Other benign lesions include thyroglossal duct cysts, vascular anomalies, laryngocele, ranula (mucocele), teratoma, dermoid cyst, and thymic cyst. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Congenital neck mass'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Inflammatory neck masses are most commonly due to infection, typically reactive viral lymphadenopathy. Lymph node enlargement due to infectious mononucleosis may take up to six weeks to resolve; other viral adenopathy generally resolves in two weeks. Suppurative lymphadenopathy usually results from S aureus and group A beta streptococcal infections of the pharynx or skin; abscess drainage may be indicated based on a patient's response to antibiotic therapy. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Infectious inflammatory disorders'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Neck masses that result from metastatic disease are predominantly related to metastatic squamous cell carcinoma arising from the aerodigestive tract. Metastatic nodes in the posterior triangle are often related to nasopharyngeal carcinoma, whereas nodes along the upper jugular chain drain from the oral cavity, oropharynx, and larynx. Isolated supraclavicular nodes should raise concern for tracheobronchial, distal esophageal, or stomach carcinoma. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Metastatic head and neck carcinoma'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      While the majority of thyroid masses are benign nodules and cysts, malignancy must be considered. Symptoms of hoarseness or a history of radiation exposure in the setting of a new thyroid mass should increase the suspicion for malignancy. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Thyroid masses'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Malignancy is more common in tumors of the submandibular gland than the parotid gland (50 versus 20 percent of tumors, respectively). Most benign salivary gland tumors are pleomorphic adenomas and present as asymptomatic enlarging masses. Pain, cranial nerve deficits, or overlying skin changes herald the presence of malignancy. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Salivary gland neoplasm'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other neoplastic disorders presenting as neck masses include paragangliomas, lymphoma, and lipomas. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Neoplastic disorders'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11608/abstract/1\">",
"      Work WP. Cysts and congenital lesions of the parotid gland. Otolaryngol Clin North Am 1977; 10:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11608/abstract/2\">",
"      McGurk M. Management of the ranula. J Oral Maxillofac Surg 2007; 65:115.",
"     </a>",
"    </li>",
"    <li>",
"     Pincus RL. Congenital neck masses and cysts. In: Head &amp; Neck Surgery - Otolaryngology, 3rd ed., Bailey BJ (Ed), Lippincott Williams &amp; Wilkins, New York 2001. p.933.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11608/abstract/4\">",
"      Enepekides DJ. Management of congenital anomalies of the neck. Facial Plast Surg Clin North Am 2001; 9:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11608/abstract/5\">",
"      Lin ST, Tseng FY, Hsu CJ, et al. Thyroglossal duct cyst: a comparison between children and adults. Am J Otolaryngol 2008; 29:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11608/abstract/6\">",
"      Josephson GD, Spencer WR, Josephson JS. Thyroglossal duct cyst: the New York Eye and Ear Infirmary experience and a literature review. Ear Nose Throat J 1998; 77:642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11608/abstract/7\">",
"      Marler JJ, Mulliken JB. Current management of hemangiomas and vascular malformations. Clin Plast Surg 2005; 32:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11608/abstract/8\">",
"      April MM, Ward RF, Garelick JM. Diagnosis, management, and follow-up of congenital head and neck teratomas. Laryngoscope 1998; 108:1398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11608/abstract/9\">",
"      Prasad HK, Bhojwani KM, Shenoy V, Prasad SC. HIV manifestations in otolaryngology. Am J Otolaryngol 2006; 27:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11608/abstract/10\">",
"      Gluckman JL, Robbins KT, Fried MP. Cervical metastatic squamous carcinoma of unknown or occult primary source. Head Neck 1990; 12:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11608/abstract/11\">",
"      Talmi YP, Hoffman HT, Horowitz Z, et al. Patterns of metastases to the upper jugular lymph nodes (the \"submuscular recess\"). Head Neck 1998; 20:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11608/abstract/12\">",
"      Coleman SC, Smith JC, Burkey BB, et al. Long-standing lateral neck mass as the initial manifestation of well-differentiated thyroid carcinoma. Laryngoscope 2000; 110:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11608/abstract/13\">",
"      Pinkston JA, Cole P. Incidence rates of salivary gland tumors: results from a population-based study. Otolaryngol Head Neck Surg 1999; 120:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11608/abstract/14\">",
"      Gujrathi CS, Donald PJ. Current trends in the diagnosis and management of head and neck paragangliomas. Curr Opin Otolaryngol Head Neck Surg 2005; 13:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11608/abstract/15\">",
"      Dailey SH, Sataloff RT. Lymphoma: an update on evolving trends in staging and management. Ear Nose Throat J 2001; 80:164.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6857 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-8641F3AC89-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_21_11608=[""].join("\n");
var outline_f11_21_11608=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ANATOMY OF THE NECK AND LYMPH NODE DRAINAGE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CONGENITAL NECK MASS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Branchial cleft cyst",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Thyroglossal duct cyst",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Vascular anomalies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Laryngocele",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Ranula",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Teratoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Dermoid cyst",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Thymic cyst",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      INFLAMMATORY NECK MASS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Infectious inflammatory disorders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Reactive viral lymphadenopathy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Bacterial lymphadenopathy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19037800\">",
"      - Parasitic lymphadenopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Noninfectious inflammatory disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      NEOPLASTIC DISORDERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Metastatic head and neck carcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Thyroid masses",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Salivary gland neoplasm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Paragangliomas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Schwannoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Lymphoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Lipoma and benign skin cysts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/6857\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/6857|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?41/25/42388\" title=\"figure 1\">",
"      Compartments of neck",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/53/19285\" title=\"figure 2\">",
"      Lymph nodes head and neck",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/23/25972\" title=\"figure 3\">",
"      Branchial cleft cysts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/6857|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/62/31723\" title=\"table 1\">",
"      Lymphatic drainage of the head and neck",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/2/24620\" title=\"table 2\">",
"      Causes of lymphadenopathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/40/32392?source=related_link\">",
"      Anterior mediastinal mass lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/51/6970?source=related_link\">",
"      Castleman's disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/1/30744?source=related_link\">",
"      Causes of peripheral lymphadenopathy in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21559?source=related_link\">",
"      Cervicofacial actinomycosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/43/16058?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of brucellosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/10/30888?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of tularemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27610?source=related_link\">",
"      Clinical presentation and diagnosis of non-Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/59/1977?source=related_link\">",
"      Congenital anomalies of the jaw, mouth, oral cavity, and pharynx",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/42/37543?source=related_link\">",
"      Congenital anomalies of the larynx",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/15/37111?source=related_link\">",
"      Cystic thyroid nodules",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/17/24857?source=related_link\">",
"      Diagnostic approach to and initial treatment of cervical lymphadenitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28506?source=related_link\">",
"      Diagnostic approach to and treatment of thyroid nodules",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/27/8632?source=related_link\">",
"      Etiology and clinical manifestations of cervical lymphadenitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/23/5495?source=related_link\">",
"      Evaluation and diagnosis of infantile hemangiomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/24/7558?source=related_link\">",
"      Evaluation of a neck mass",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/10/39080?source=related_link\">",
"      Evaluation of peripheral lymphadenopathy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31018?source=related_link\">",
"      Infectious mononucleosis in adults and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/33/29206?source=related_link\">",
"      Initial evaluation and diagnosis of Hodgkin lymphoma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12248?source=related_link\">",
"      Kawasaki disease: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/60/25546?source=related_link\">",
"      Management of infantile hemangiomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/47/23289?source=related_link\">",
"      Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/6/32874?source=related_link\">",
"      Overview of Hodgkin lymphoma in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/44/30407?source=related_link\">",
"      Overview of head and neck cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/42/13994?source=related_link\">",
"      Overview of nontuberculous mycobacterial lymphadenitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/13/21720?source=related_link\">",
"      Paragangliomas of the head and neck",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/44/9927?source=related_link\">",
"      Salivary gland tumors: Epidemiology, diagnosis, evaluation, and staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/2/13353?source=related_link\">",
"      The stages and natural history of HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/16/25864?source=related_link\">",
"      Thyroglossal duct cysts and ectopic thyroid",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/38/16999?source=related_link\">",
"      Toxoplasmosis in immunocompetent hosts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/2/37925?source=related_link\">",
"      Treatment of cat scratch disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/7/27768?source=related_link\">",
"      Tuberculous lymphadenitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/21/30038?source=related_link\">",
"      Vascular lesions in the newborn",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_21_11609="Midshaft forearm fractures in children";
var content_f11_21_11609=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Midshaft forearm fractures in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/21/11609/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/21/11609/contributors\">",
"     Paula Schweich, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/21/11609/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/21/11609/contributors\">",
"     Richard G Bachur, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/21/11609/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/21/11609/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/21/11609/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 18, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Childhood midshaft forearm fractures are very common and typically occur after a fall on an outstretched hand. Early assessment should focus on ruling out an open fracture, neurovascular compromise, acute compartment syndrome,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    associated injuries, especially a supracondylar fracture.",
"   </p>",
"   <p>",
"    Initial care of nondisplaced fractures consists of splinting, pain control, and measures aimed at reducing swelling. For most displaced or angulated midshaft forearm fractures, closed reduction by an experienced clinician or orthopedic surgeon is adequate treatment and is often accomplished under sedation in the emergency department.",
"   </p>",
"   <p>",
"    Midshaft fractures of the forearm will be addressed here. The diagnosis and management of distal forearm fractures in children and other upper extremity fractures are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/14/14569?source=see_link\">",
"     \"Initial management of distal forearm fractures in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/22/25961?source=see_link\">",
"     \"Evaluation and management of supracondylar fractures in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/13/30934?source=see_link\">",
"     \"Midshaft humeral fractures in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Forearm fractures are the most common fractures in children, representing 40 to 50 percent of all childhood fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. In one large series, forearm shaft fractures of the radius ranked as the third most common fracture after distal radial fractures and supracondylar humeral fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/3\">",
"     3",
"    </a>",
"    ]. In addition, midshaft forearm fractures are the most common sites for refracture in children and among the most common sites of pediatric open fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Forearm fractures have been associated with falls from playground equipment (eg, monkey bars) and from backyard trampolines [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. However, any fall with adequate force may result in fracture.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PERTINENT ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The bones, muscles, ligaments, and tendons all work together in stabilizing the forearm. An interosseous membrane connects the radius and ulna, and the radius rotates around the ulna during supination and pronation of the forearm (",
"    <a class=\"graphic graphic_figure graphicRef78612 \" href=\"UTD.htm?23/13/23760\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef64025 \" href=\"UTD.htm?36/52/37698\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/1,7-10\">",
"     1,7-10",
"    </a>",
"    ]. The two areas where the radius and ulna meet, at the elbow and the wrist, are called the radioulnar articulations. Because of the interosseous membrane and these articulations, any disruption or fracture of one bone is usually accompanied by fracture to the other (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef58106 \" href=\"UTD.htm?32/31/33279\">",
"     image 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/1,4,9\">",
"     1,4,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If only one bone appears to be fractured, the clinician should check the proximal and distal joints for injury to the other bone or the joint.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MECHANISM OF INJURY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most both bone midshaft forearm fractures in children result from a fall onto an outstretched hand (FOOSH) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/2,8,9\">",
"     2,8,9",
"    </a>",
"    ]. A direct blow to the middle of the forearm may cause an isolated fracture of the midshaft ulna (\"nightstick fracture\") or, less commonly, the radius.",
"   </p>",
"   <p>",
"    Midshaft forearm fractures are not typically associated with multiple trauma. However, children who fall from a height greater than three times their standing height or sustain a midshaft forearm fracture as a result of another major trauma mechanism (",
"    <a class=\"graphic graphic_table graphicRef57293 \" href=\"UTD.htm?0/42/684\">",
"     table 1",
"    </a>",
"    ) are at risk for multiple trauma and warrant a complete physical examination and appropriate ancillary studies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/11/40119?source=see_link&amp;anchor=H7#H7\">",
"     \"Approach to the initially stable child with blunt or penetrating injury\", section on 'Approach to blunt trauma'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/16/29962?source=see_link&amp;anchor=H8#H8\">",
"     \"Trauma management: Approach to the unstable child\", section on 'Initial approach'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Intentional trauma should be suspected in a child with an isolated ulna fracture (nightstick fracture) or a complete midshaft radius and ulna fracture without a history of injury. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/30/13802?source=see_link\">",
"     \"Orthopedic aspects of child abuse\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PHYSICAL FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The child with a midshaft forearm fracture typically has swelling, pain, and deformity at the middle forearm with limited range of motion of the hand, wrist, and elbow.",
"   </p>",
"   <p>",
"    Once the clinician has performed a general physical examination to exclude other injuries, the examination can focus on the forearm. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Associated injuries'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In a patient with severe pain, analgesia (eg, intravenous",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32233?source=see_link\">",
"     morphine",
"    </a>",
"    0.1 to 0.15",
"    <span class=\"nowrap\">",
"     mg/kg;",
"    </span>",
"    maximum single dose: 10 mg) prior to examination is necessary to enable the child to cooperate with the examination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Inspection and palpation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinician should examine the arm from the clavicle down, noting the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Arm position",
"     </li>",
"     <li>",
"      Location of deformity",
"     </li>",
"     <li>",
"      Skin wounds &ndash; Careful inspection of the entire forearm is necessary to detect an open fracture (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef77702 \" href=\"UTD.htm?17/59/18353\">",
"       image 2",
"      </a>",
"      ). The bone may have poked through the skin and then retracted, leaving a small puncture. In contrast to an abrasion or puncture from the outside of the arm overlying the fracture site, these small punctures resulting from the fracture tend to ooze blood. If blood can be expressed through the hole, it is an open fracture. This clinical tool can be used to detect even a small open fracture.",
"     </li>",
"     <li>",
"      Presence and location of tenderness",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      swelling",
"     </li>",
"     <li>",
"      Evidence of injury in the wrist or elbow region",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Neurovascular examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Assessment of neurovascular status is particularly important as nerve deficits, especially median nerve injury, are found in a significant number of children with midshaft forearm fractures.",
"   </p>",
"   <p>",
"    The clinician should evaluate the sensory and motor function of the median, radial, and ulnar nerves (",
"    <a class=\"graphic graphic_table graphicRef53902 \" href=\"UTD.htm?24/11/24763\">",
"     table 2",
"    </a>",
"    ).",
"    <br/>",
"    <br/>",
"    The following tests establish motor function of the major nerves while minimizing extremity movements:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      \"OK\" sign (alternatively, ask the patient to pinch your hand): anterior interosseous nerve (branch of median nerve and radial nerve) (",
"      <a class=\"graphic graphic_picture graphicRef52203 \" href=\"UTD.htm?25/33/26142\">",
"       picture 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Finger spread against resistance or holding a piece of paper firmly between the middle and ring fingers: ulnar nerve (",
"      <a class=\"graphic graphic_figure graphicRef75179 \" href=\"UTD.htm?23/56/24463\">",
"       figure 3",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Thumb's up sign: radial nerve (",
"      <a class=\"graphic graphic_figure graphicRef51625 \" href=\"UTD.htm?14/7/14463\">",
"       figure 4",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The clinician should perform testing of two point discrimination in children over five years of age to assess sensory function. Using a folded paper clip, the clinician assesses the ability to recognize two points, 5 mm apart, applied simultaneously to the skin as distinct from a single point in the following areas on the hand:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dorsal web space &ndash; Innervated by the radial nerve",
"     </li>",
"     <li>",
"      Index (pointer) finger &ndash; Innervated by the median nerve",
"     </li>",
"     <li>",
"      Pinky (or little finger) &ndash; Innervated by the ulnar nerve",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although nerve injuries may rarely be associated with long-term sequelae, the majority are neurapraxias, ie, temporary loss of nerve function (especially motor function) without anatomical nerve disruption [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Radial and ulnar pulse &ndash; Blood vessel injuries are rare with forearm fractures, but occur commonly with supracondylar fractures that may accompany a forearm fracture. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/22/25961?source=see_link&amp;anchor=H6#H6\">",
"       \"Evaluation and management of supracondylar fractures in children\", section on 'Vascular anatomy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Range of motion of the arm (eg, supination, pronation, flexion, and extension) &ndash; The patient should be asked to perform active motion, if possible. The clinician should NOT perform passive range of motion if a fracture is suspected.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Acute compartment syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Compartment syndrome may rarely occur prior to or after definitive orthopedic care of a midshaft forearm fracture. It is more common in children with forearm fracture who also have a supracondylar fracture [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. The following findings suggest a developing compartment syndrome:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Excessive swelling and ecchymosis at the elbow [",
"      <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/13\">",
"       13",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Increasing forearm pain",
"     </li>",
"     <li>",
"      Increased pain upon passive extension of the fingers",
"     </li>",
"     <li>",
"      Tenseness of the affected muscle compartment",
"     </li>",
"     <li>",
"      Cold hand with poor perfusion, pallor, and diminished or absent radial pulse (late finding)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Once the clinician suspects an acute compartment syndrome, compartment pressures should be measured and emergent consultation with an orthopedic surgeon should occur. Fasciotomy constitutes definitive treatment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/57/8090?source=see_link&amp;anchor=H15#H15\">",
"     \"Acute compartment syndrome of the extremities\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Associated injuries",
"    </span>",
"    &nbsp;&mdash;&nbsp;When there is an isolated fracture evident in the radius or ulna, the clinician should check the joints above and below for other injuries.",
"   </p>",
"   <p>",
"    Up to 5 percent of forearm fractures in children are complicated by supracondylar fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/14\">",
"     14",
"    </a>",
"    ]. Thus, the elbow warrants careful inspection for swelling",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    deformity and palpation for bony tenderness. Radiographs of the forearm in children with fracture should visualize the wrist and the elbow. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Radiographic views'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In addition, shoulder and clavicle injuries may occur, and any deformity, swelling, or bony tenderness in these areas warrants radiographic investigation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     RADIOGRAPHIC FINDINGS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Radiographic technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;When obtaining radiographs in the child with a suspected midshaft forearm fracture, the goal is to obtain the necessary films with minimal movement of the extremity. In patients with an obvious deformity or high suspicion for a displaced fracture, analgesia (eg, intravenous",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32233?source=see_link\">",
"     morphine",
"    </a>",
"    0.1 to 0.15",
"    <span class=\"nowrap\">",
"     mg/kg,",
"    </span>",
"    maximum single dose: 10 mg) and splinting are advisable prior to obtaining radiographs. Otherwise, a sling typically provides adequate support of nondisplaced fractures and allows for radiographs to be obtained more easily. (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Analgesia and splinting'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Radiographic views",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients with suspected forearm fractures need a true AP and lateral view of the injured forearm that includes the wrist and distal humerus. A good AP view of the forearm should have minimal superimposition of the radial tuberosity (located on the proximal radius) over the proximal ulna, and similar radiographic density for the proximal and distal forearm (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef60234 \" href=\"UTD.htm?30/1/30750\">",
"     image 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/15\">",
"     15",
"    </a>",
"    ]. A true lateral view of the forearm has superimposition of the radial head and the ulnar coronoid process at the proximal end, superimposition of the radius and ulna at the distal end, a view of the soft tissues around both bones, and the elbow flexed at 90 degrees (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef65236 \" href=\"UTD.htm?25/32/26126\">",
"     image 4",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When describing and documenting a forearm fracture, the key elements include the location, angulation, displacement, and presence of bony rotation [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The forearm is divided into the proximal third, middle third, and distal third.",
"     </li>",
"     <li>",
"      On the lateral view, the displacement is defined by the displacement of the distal fragment (dorsal or volar).",
"     </li>",
"     <li>",
"      The angulation is described by the direction of the apex of the deformity (dorsal or volar) and the degree of angulation.",
"     </li>",
"     <li>",
"      Rotation of the fracture is judged by a break in the smooth curve of the bone, or change in the diameter of the bone or width of the cortex of the two fragments [",
"      <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/8,9\">",
"       8,9",
"      </a>",
"      ]. Most displacements are also rotated.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If there is displacement or angulation on the AP view, descriptions are similar, but in the radial or ulnar direction. If there is concern about an elbow fracture or dislocation, separate elbow radiographs are obtained [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/58/43941?source=see_link&amp;anchor=H3#H3\">",
"     \"General principles of fracture management: Bone healing and fracture description\", section on 'Fracture description'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20104?source=see_link&amp;anchor=H2#H2\">",
"     \"General principles of fracture management: Fracture patterns and description in children\", section on 'Fracture description in children'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Classification",
"    </span>",
"    &nbsp;&mdash;&nbsp;Forearm fractures are described using the following elements:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fracture type &ndash; Closed versus open",
"     </li>",
"     <li>",
"      Bone involvement &ndash; Single or both bone fracture",
"     </li>",
"     <li>",
"      Location &ndash; Distal, middle, or proximal third",
"     </li>",
"     <li>",
"      Fracture pattern &ndash; Plastic deformation, greenstick, complete, or comminuted",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Specific fractures",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Plastic deformations",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the bone (usually the diaphysis of the ulna) is bent on radiograph but not fractured, it may be bowed (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef58576 \" href=\"UTD.htm?30/22/31072\">",
"     image 5",
"    </a>",
"    ). The arm will typically look excessively curved as well.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Greenstick fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;A greenstick fracture is a complete fracture of the tension side of the cortex and a plastic deformation, or buckling, of the compression side, most commonly in the diaphysis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/1,2,7\">",
"     1,2,7",
"    </a>",
"    ]. This type of injury is usually from a rotational force (",
"    <a class=\"graphic graphic_figure graphicRef58677 \" href=\"UTD.htm?16/55/17266\">",
"     figure 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef65605 \" href=\"UTD.htm?25/63/26608\">",
"     image 6",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef70786 \" href=\"UTD.htm?41/47/42750\">",
"     image 7",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/8,16\">",
"     8,16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Complete fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;A complete fracture is a fracture through both cortices of the radius",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ulna, often with displacement (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef67071 \" href=\"UTD.htm?4/57/5009\">",
"     image 8",
"    </a>",
"    ). Because children's bones are more flexible than those of adults, these pediatric fractures are rarely comminuted. The bony segments assume the position that is dictated by the muscle forces exerted on the bone [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/1,4,8\">",
"     1,4,8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Comminuted fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Midshaft fractures with multiple bony fragments are uncommon in children and typically arise from a high energy mechanism (eg, high speed motor vehicle collision).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Associated fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Forearm fractures are associated with supracondylar fractures in up to 5 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/11\">",
"     11",
"    </a>",
"    ]. The combination of supracondylar and forearm fractures is termed the \"floating elbow\" and increases the possibility of compartment syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/12\">",
"     12",
"    </a>",
"    ]. For this reason, AP and lateral radiographs of the forearm should include the distal humerus in all patients with forearm fractures.",
"   </p>",
"   <p>",
"    Proximal humerus, clavicle, wrist, and hand fractures may also occur with a midshaft forearm fracture. Deformity",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bony tenderness during physical examination dictates appropriate radiographic assessment of these areas in selected patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     INITIAL TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goals for initial care of midshaft forearm fractures in children are to reverse vascular compromise or an acute compartment syndrome, provide analgesia, and immobilize the fracture.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Absent pulse",
"    </span>",
"    &nbsp;&mdash;&nbsp;The emergency clinician should promptly identify children with vascular insufficiency and emergently involve an orthopedic surgeon with appropriate pediatric expertise. Rarely, these children may require partial closed reduction in the emergency department in an attempt to restore distal circulation. Patients who display a cold, white, or cyanotic hand despite reduction attempts require operative exploration and vascular repair.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Compartment syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Compartment syndrome may rarely occur prior to or after definitive orthopedic care of a midshaft forearm fracture. It is more common in children with forearm fracture who also have a supracondylar fracture [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/11,12\">",
"     11,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When compartment syndrome is suspected based on clinical findings, immediate management includes relieving all external pressure on the compartment. Any dressing, splint, cast, or other restrictive covering should be removed. The limb should NOT be elevated. Elevation can diminish arterial inflow and exacerbate ischemia. Analgesics should be given.",
"   </p>",
"   <p>",
"    Suspected compartment syndrome should prompt emergent compartment pressure measurement and orthopedic consultation. Definitive treatment consists of fasciotomy to decompress all involved compartments. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/57/8090?source=see_link&amp;anchor=H10#H10\">",
"     \"Acute compartment syndrome of the extremities\", section on 'Measurement of compartment pressures'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/57/8090?source=see_link&amp;anchor=H15#H15\">",
"     \"Acute compartment syndrome of the extremities\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Analgesia and splinting",
"    </span>",
"    &nbsp;&mdash;&nbsp;For children with no sign of compartment syndrome, initial therapy consists of pain management and immobilization to prevent worsened alignment of the fracture.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Parenteral analgesia (eg, intravenous",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32233?source=see_link\">",
"       morphine",
"      </a>",
"      0.1 to 0.15",
"      <span class=\"nowrap\">",
"       mg/kg;",
"      </span>",
"      maximum single dose: 10 mg) is most appropriate for initial pain control in patients with moderate to severe pain and should be given prior to radiographic evaluation. Oral analgesia (eg,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/48/7946?source=see_link\">",
"       ibuprofen",
"      </a>",
"      10",
"      <span class=\"nowrap\">",
"       mg/kg)",
"      </span>",
"      may suffice for patients who have suffered a nondisplaced forearm fracture. In most circumstances, pain relief will result in an improved ability to assess neurovascular status in the apprehensive child. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/15/44280?source=see_link\">",
"       \"Evaluation and management of pain in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Immobilization of obviously deformed fractures prior to radiographs promotes pain relief and helps to prevent additional arm injury from inadvertent arm movement. In this situation, the arm should be splinted \"as it lies\" (typically a sugar tong splint using prefabricated splinting material or eight layers of plaster with under cast padding (eg, Webril&reg;) and loosely applied elastic bandages (eg, Ace&reg; wrap)) (",
"      <a class=\"graphic graphic_figure graphicRef50501 \" href=\"UTD.htm?36/26/37281\">",
"       figure 6",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/54/15208?source=see_link&amp;anchor=H12#H12\">",
"       \"Splinting of musculoskeletal injuries\", section on 'Sugar tong splints'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Neurovascular status should be checked before and after splinting. If any further compromise is found after immobilization, then the splinting material should be removed and the arm position adjusted.",
"   </p>",
"   <p>",
"    Patients with no or minimal deformity may be placed in a sling for comfort prior to radiographic assessment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR ORTHOPEDIC CONSULTATION OR REFERRAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prompt orthopedic consultation should be obtained in any of the following midshaft forearm fractures:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Open fractures",
"     </li>",
"     <li>",
"      Fractures with neurovascular compromise or compartment syndrome",
"     </li>",
"     <li>",
"      Complete both bones fractures (if the clinician is not experienced with reduction)",
"     </li>",
"     <li>",
"      Angulated fractures (if the clinician is not experienced with reduction)",
"     </li>",
"     <li>",
"      Single displaced radius fractures with intact ulna where a difficult reduction is anticipated",
"     </li>",
"     <li>",
"      Plastic deformation of one or both bones",
"     </li>",
"     <li>",
"      Forearm fractures with concomitant dislocations (eg, Monteggia or Galeazzi)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Clinicians who are experienced in fracture reduction and cast or splint immobilization of the reduced fracture may choose to provide this care for angulated or complete closed midshaft fractures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     DEFINITIVE CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Closed reduction followed by casting or splinting provides definitive treatment for most pediatric midshaft forearm fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/2,4\">",
"     2,4",
"    </a>",
"    ]. The availability of safe pediatric sedation and analgesia outside of the operating room allows for many reductions to be performed in the emergency department. Clinicians who are experienced in fracture reduction and cast or splint immobilization of the reduced fracture may choose to provide this care for midshaft fractures and arrange for orthopedic follow-up. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/23/43384?source=see_link\">",
"     \"Procedural sedation in children outside of the operating room\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If parents choose to stay with the child during the procedure, they should be warned about the child's appearance during sedation, including the possibility that the child will cry out, vomit, or need airway support; the sound of moving bones during the reduction; and the possible need for multiple attempts",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    significant force to successfully reduce the fracture. In addition, they should be seated where they will be comfortable and out of the way.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Plastic deformation",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the deformation is less than 20 degrees or if the deformity occurs in a young child (&lt;4 years of age), angulation is often corrected with immobilization alone [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/17\">",
"     17",
"    </a>",
"    ]. If there is an associated angulated fracture of the radius, then closed reduction will typically straighten the bowed ulna, as well (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef52057 \" href=\"UTD.htm?30/55/31601\">",
"     image 9",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef55716 \" href=\"UTD.htm?9/8/9344\">",
"     image 10",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    However, more extensive plastic deformation can result in narrowing of the interosseous space, limiting future pronation and supination and requires prompt referral to an orthopedist (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef58576 \" href=\"UTD.htm?30/22/31072\">",
"     image 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef75630 \" href=\"UTD.htm?30/59/31679\">",
"     figure 7",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Greenstick fracture",
"    </span>",
"    &nbsp;&mdash;&nbsp;If a reduction is necessary, it is done with the goal of reversing the mechanism of injury, including the angulation, displacement, and rotation. In most circumstances, rotating the palm of the hand toward the deformity while applying pressure just proximal to the apex of the deformity suffices (eg, pronation for apex-volar deformity and supination for an apex-dorsal deformity) (",
"    <a class=\"graphic graphic_figure graphicRef58677 \" href=\"UTD.htm?16/55/17266\">",
"     figure 5",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    To ensure complete reduction and healing, some experts recommend completion of the break through the non-fractured side [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/18-20\">",
"     18-20",
"    </a>",
"    ]. However, observational studies have shown good healing without completion of the greenstick fracture [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among 99 total children with forearm fractures, residual angulation was less in children with greenstick fractures than in those with complete fractures (5 versus 7 degrees, p = 0.02) [",
"      <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Reangulation during healing occurred less commonly for the 151 children with greenstick fractures than for the 47 children with complete fractures (10 versus 25 percent, p = 0.08) [",
"      <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Once reduced, the arm should be immobilized in a sugar tong splint or long arm cast with molding that provides three-point fixation to hold the reduction in place (",
"    <a class=\"graphic graphic_figure graphicRef52462 \" href=\"UTD.htm?15/46/16096\">",
"     figure 8",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/1,10\">",
"     1,10",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H30\">",
"     'Immobilization and casting basics'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    For very minimally angulated greenstick fractures, the fracture can be casted without previous reduction, and then gently reduced while the cast materials are setting. The reduction is held in place with a three-point smoothly molded cast (",
"    <a class=\"graphic graphic_figure graphicRef52462 \" href=\"UTD.htm?15/46/16096\">",
"     figure 8",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Even fractures with intact periosteum and no displacement can become malaligned during or after closed reduction and warrant orthopedic follow-up within 7 to 10 days to evaluate for redisplacement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Complete fracture",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ability to adequately reduce these fractures in the emergency department depends on the degree of angulation, displacement, and overlapping of the fracture fragments:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Very minimally angulated and displaced midshaft fractures can be casted without reduction and then gently reduced while the cast is on and setting. The reduction is held in place with a three-point mold (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef65018 \" href=\"UTD.htm?13/46/14050\">",
"       image 11",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      For significantly angulated",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      displaced fractures (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef67071 \" href=\"UTD.htm?4/57/5009\">",
"       image 8",
"      </a>",
"      ), traction may be applied by using finger traps prior to and during the reduction. Counter traction may be applied by slinging a sheet over the upper arm and stepping on the ends or by using weights slung over the distal humerus, or by hand. Adequate reduction of a complete fracture may take several attempts. Portable fluoroscopy is useful to check the adequacy of reduction during the procedure [",
"      <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/22\">",
"       22",
"      </a>",
"      ]. Malrotation of the radius and ulna must also be corrected by supination or pronation; rotational alignment of the radius is more important than that of the ulna. Maintaining reduction with good cast technique is essential. (See",
"      <a class=\"local\" href=\"#H30\">",
"       'Immobilization and casting basics'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      If both bones are significantly overlapping, the clinician should anticipate a very difficult reduction that will be unstable. In these instances, an orthopedic surgeon should be consulted for possible open reduction and internal fixation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Midshaft complete fractures tend to be very unstable despite appropriate reduction and immobilization (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef67071 \" href=\"UTD.htm?4/57/5009\">",
"     image 8",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef58106 \" href=\"UTD.htm?32/31/33279\">",
"     image 1",
"    </a>",
"    ). Midshaft complete fractures may require open reduction and internal fixation if adequate closed reduction is not achieved or cannot be maintained, especially in children over ten years of age (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef58259 \" href=\"UTD.htm?5/9/5266\">",
"     image 12",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Once a fracture reduction is performed, the child should follow up with an orthopedic surgeon within one week for radiographic assessment of fracture positioning. The patient should be seen on a regular basis for the first few weeks to monitor for any loss of reduction [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/1,4\">",
"     1,4",
"    </a>",
"    ]. Up to 25 percent of complete forearm fractures displace during follow-up despite adequate initial closed reduction and casting and will require repeat closed reduction or surgical intervention [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Comminuted fracture",
"    </span>",
"    &nbsp;&mdash;&nbsp;These fractures are less common in children and are often associated with high energy mechanisms of injury or open fractures. Prompt orthopedic consultation for open reduction and internal fixation is typically necessary.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Immobilization and casting basics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once reduced, the clinician may choose to immobilize the fracture using a combined sugar tong and long arm splint or a cast. If a splint is applied, the patient is typically referred for cast application by an orthopedic surgeon within two to five days. This approach allows time for the swelling to go down before the cast is placed but may risk loss of reduction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/54/15208?source=see_link&amp;anchor=H8#H8\">",
"     \"Splinting of musculoskeletal injuries\", section on 'Upper extremity splints'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An overview of casting is provided separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/23/1400?source=see_link&amp;anchor=H2#H2\">",
"     \"General principles of definitive fracture management\", section on 'Casting'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Key aspects of casting midshaft forearm fractures are as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Arm position &ndash; After a fracture reduction, the elbow should be placed at 90 degrees before ANY casting material is applied; if it is flexed after material is applied it causes bunching and irritation at the elbow. Typically, a second person is needed to hold the arm (by the fingers) in the proper position.",
"     </li>",
"     <li>",
"      Materials &ndash; The layers of the cast consist of stockinette next to the skin, cotton padding (eg, two inch Webril&reg;) that is rolled with one half inch overlap, and two inch fiberglass or plaster casting material. Extra padding should be applied to common pressure points at the wrist and elbow. It is important to ensure no major wrinkles exist in the stockinette and the padding before casting material is applied.",
"     </li>",
"     <li>",
"      Molding &ndash; Three-point molding of the forearm portion of the cast maintains the fracture reduction and allows the clinician to mold the cast without causing pressure points. The palm of one hand pushes gently distal to the fracture on the side of the intact periosteum, while the palm of the other hand pushes gently proximal to the fracture on the opposite side of the arm. An assistant's hand is placed more proximally on the arm (below the elbow) on the same side as the most distal hand. Once completed, the cast should be wider in the horizontal diameter than in the vertical diameter when viewed on end (vertical to horizontal diameter ratio 0.7) and the ulnar border should be straight (",
"      <a class=\"graphic graphic_figure graphicRef52462 \" href=\"UTD.htm?15/46/16096\">",
"       figure 8",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Forearm position in the cast &ndash; The cast should be in neutral position with respect to supination and pronation of the hand [",
"      <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/2\">",
"       2",
"      </a>",
"      ]. Although some orthopedists prefer the wrist to be casted in slight flexion with ulnar deviation to counteract opposing muscles, an observational study of 109 children with distal forearm fractures concluded that the position of immobilization (neutral, pronation, or supination) does not appear to affect maintenance of fracture reduction and residual angulation [",
"      <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Length of cast &ndash; A long arm cast should be placed on all reduced midshaft forearm fractures.",
"     </li>",
"     <li>",
"      Post-casting neurovascular assessment &ndash; The patient should have good perfusion of the fingers and be able to fully extend his or her fingers and thumb actively and passively after casting [",
"      <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/8\">",
"       8",
"      </a>",
"      ]. Poor perfusion, pain on finger extension, or limitation of finger or thumb motion suggests tendon",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      muscle entrapment or a tight cast.",
"     </li>",
"     <li>",
"      Assessment of reduction and casting &ndash; After closed reduction and casting, post-reduction radiographs are obtained in the radiology department or at the bedside using fluoroscopy [",
"      <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/9\">",
"       9",
"      </a>",
"      ]. Bedside fluoroscopy has the advantage of timeliness, continued ability to monitor the patient after sedation, and lower radiation exposure.",
"     </li>",
"     <li>",
"      Once adequate fracture alignment and cast molding is documented radiographically, the child is fully recovered from sedation, and cast instructions have been provided, the child may be discharged home. (See",
"      <a class=\"local\" href=\"#H31\">",
"       'Follow-up care'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     FOLLOW-UP CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients should be provided with a sling and instructed to keep the fracture site elevated above the level of the heart as much as possible for the first 48 hours after injury.",
"   </p>",
"   <p>",
"    Caretakers and children who received a cast should be given detailed cast care instructions. (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?25/21/25937?source=see_link\">",
"     \"Patient information: Cast and splint care (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Midshaft forearm fractures that undergo closed reduction should be evaluated by an orthopedic surgeon within a week. Subsequently, the patient is seen on a frequent basis for the first few weeks to monitor for any redisplacement or angulation [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/4,7\">",
"     4,7",
"    </a>",
"    ]. Up to 25 percent of greenstick or complete fractures displace during follow-up despite adequate initial closed reduction and casting [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/21\">",
"     21",
"    </a>",
"    ]. These fractures require repeat closed reduction or surgical intervention.",
"   </p>",
"   <p>",
"    Children who have received operative care should be admitted for 24 to 48 hour observation of neurovascular status and soft tissue compartments. Once discharged, these patients are followed closely and may require weekly orthopedic evaluation with radiographs to determine the optimal timing for subsequent hardware removal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Home pain management",
"    </span>",
"    &nbsp;&mdash;&nbsp;A small trial found that after reduction and casting, approximately 80 percent of patients with arm fractures achieve adequate analgesia with nonsteroidal antiinflammatory medications (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/48/7946?source=see_link\">",
"     ibuprofen",
"    </a>",
"    10",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    every six hours; maximum dose 800 mg per dose) during the first three days after care [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/23\">",
"     23",
"    </a>",
"    ]. However, up to 20 percent of patients may require oral opioid medication (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?38/23/39287?source=see_link\">",
"     oxycodone",
"    </a>",
"    0.15",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    every four hours; maximum dose: 5 mg) for adequate pain control during the first 72 hours. Thus, some clinicians may choose to provide a limited prescription to be used as needed. At 72 hours, continued pain requiring opioid analgesia is an indication for reevaluation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications from midshaft forearm fractures are rare. Loss of alignment after reduction and refracture comprise the most common complications following midshaft forearm fracture care [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/2,4,21,24\">",
"     2,4,21,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Refractures typically occur approximately six months after injury [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/25\">",
"     25",
"    </a>",
"    ]. The risk of refracture is significantly higher in patients who sustained greenstick fractures or who had internal fixation with plates or intramedullary wires [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/18,25-27\">",
"     18,25-27",
"    </a>",
"    ]. Splinting for up to two months after initial bone healing may decrease the frequency of refracture [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Delayed union or malunion occurs in less than 1 percent of midshaft fractures treated by closed reduction [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although nerve injuries may be associated with long-term sequelae, the majority are neurapraxias that will resolve within two to three months. Surgical exploration may be needed for nerve deficits that persist beyond three months [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Complex regional pain syndromes may rarely follow a midshaft forearm fracture and are identified by marked pain with light touch to the skin (allodynia), swelling, and vasomotor changes. Splinting results in worsening symptoms. Multidisciplinary pain evaluation and treatment, including physical therapy, is typically helpful. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/56/37768?source=see_link\">",
"     \"Complex regional pain syndrome in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h1\">",
"     OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prognosis for full healing and recovery of arm function following midshaft forearm fractures is very good with proper diagnosis and treatment, especially in children with nondisplaced fractures. Close follow-up with an orthopedic surgeon is necessary for these fractures because 10 to 25 percent of midshaft forearm fractures that undergo closed reduction will lose anatomic alignment during follow-up care despite appropriate initial care and casting [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11609/abstract/8,21\">",
"     8,21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?10/51/11058?source=see_link\">",
"       \"Patient information: Cast and splint care (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?25/21/25937?source=see_link\">",
"       \"Patient information: Cast and splint care (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The child with a midshaft forearm fracture typically has a history of a fall on an outstretched hand with swelling, pain, and deformity. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Physical findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with forearm fractures require a true AP and lateral plain radiograph of the injured forearm that includes the wrist and distal humerus. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Radiographic views'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients with an obvious deformity or high suspicion for a displaced fracture, analgesia (eg, intravenous",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32233?source=see_link\">",
"       morphine",
"      </a>",
"      0.1",
"      <span class=\"nowrap\">",
"       mg/kg,",
"      </span>",
"      maximum single dose: 10 mg) and splinting is advisable prior to obtaining radiographs. Otherwise, a sling typically provides adequate support of nondisplaced fractures and allows for radiographs to be obtained more easily. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Analgesia and splinting'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Specific types of midshaft forearm fractures include bowing fractures (plastic deformation) (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef58576 \" href=\"UTD.htm?30/22/31072\">",
"       image 5",
"      </a>",
"      ), greenstick fractures (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef65605 \" href=\"UTD.htm?25/63/26608\">",
"       image 6",
"      </a>",
"      ), complete fractures (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef67071 \" href=\"UTD.htm?4/57/5009\">",
"       image 8",
"      </a>",
"      ), and comminuted fractures. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Specific fractures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The emergency clinician should promptly identify children with vascular insufficiency and emergently involve an orthopedic surgeon with appropriate pediatric expertise. Rarely, these children will require partial closed reduction in the emergency department in an attempt to restore distal circulation. Patients who display a cold, cyanotic hand despite reduction attempts require emergent operative exploration and vascular repair. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Absent pulse'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Suspected compartment syndrome should prompt measurement of compartment pressure",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      emergent consultation with an orthopedic surgeon with appropriate pediatric expertise. Once confirmed by compartment pressure measurement or clinical assessment, immediate management of suspected acute compartment syndrome includes relieving all external pressure on the compartment. Definitive treatment consists of fasciotomy to decompress all involved compartments. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Compartment syndrome'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/57/8090?source=see_link&amp;anchor=H10#H10\">",
"       \"Acute compartment syndrome of the extremities\", section on 'Measurement of compartment pressures'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For children with adequate distal circulation, initial therapy consists of pain management and immobilization to prevent further displacement of the fracture. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Analgesia and splinting'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Emergent orthopedic consultation is indicated for children with an open fracture, neurovascular compromise, compartment syndrome, or forearm fracture complicated by wrist or elbow dislocation or supracondylar fracture. Prompt involvement of an orthopedic surgeon is appropriate for any patient with a displaced or angulated midshaft forearm fracture although the experienced clinician may perform the initial closed reduction. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Indications for orthopedic consultation or referral'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H25\">",
"       'Definitive care'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with nondisplaced or minimally displaced midshaft fractures may receive immobilization with a long arm splint or cast and a sling in the emergency department and follow-up with an orthopedic surgeon with appropriate pediatric expertise within one week. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Greenstick fracture'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H26\">",
"       'Plastic deformation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Price CT, Flynn JM. Management of fractures. In: Lovell and Winter's Pediatric Orthopaedics, 6th, Morrissy RT, Weinstein SL.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.1463.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11609/abstract/2\">",
"      Rodr&iacute;guez-Merch&aacute;n EC. Pediatric fractures of the forearm. Clin Orthop Relat Res 2005; :65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11609/abstract/3\">",
"      Cheng JC, Ng BK, Ying SY, Lam PK. A 10-year study of the changes in the pattern and treatment of 6,493 fractures. J Pediatr Orthop 1999; 19:344.",
"     </a>",
"    </li>",
"    <li>",
"     Mehlman CT, Wall EJ. Injuries to the shafts of the radius and ulna. In: Rockwood and Wilkins' Fractures in Children, 6th, Beaty JH, Kasser JR.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.400.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11609/abstract/5\">",
"      Black GB, Amadeo R. Orthopedic injuries associated with backyard trampoline use in children. Can J Surg 2003; 46:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11609/abstract/6\">",
"      Waltzman ML, Shannon M, Bowen AP, Bailey MC. Monkeybar injuries: complications of play. Pediatrics 1999; 103:e58.",
"     </a>",
"    </li>",
"    <li>",
"     Pizzutillo PD. Pediatric orthopaedics. In: Essentials of Musculoskeletal Care, 3rd, Griffin LY.  (Ed), American Academy of Orthopaedic Surgeons, Philadelphia 2005. p.863.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11609/abstract/8\">",
"      Noonan KJ, Price CT. Forearm and distal radius fractures in children. J Am Acad Orthop Surg 1998; 6:146.",
"     </a>",
"    </li>",
"    <li>",
"     Rang's Children's Fractures, 3rd, Rang M, Pring ME, Wenger DR.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2005.",
"    </li>",
"    <li>",
"     Waters PM, Bae DS. Fractures of the distal radius and ulna. In: Rockwood and Wilkins' Fractures in Children, 7th, Beaty JH, Kasser JR.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2010. p.292.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11609/abstract/11\">",
"      Roposch A, Reis M, Molina M, et al. Supracondylar fractures of the humerus associated with ipsilateral forearm fractures in children: a report of forty-seven cases. J Pediatr Orthop 2001; 21:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11609/abstract/12\">",
"      Templeton PA, Graham HK. The 'floating elbow' in children. Simultaneous supracondylar fractures of the humerus and of the forearm in the same upper limb. J Bone Joint Surg Br 1995; 77:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11609/abstract/13\">",
"      Carson S, Woolridge DP, Colletti J, Kilgore K. Pediatric upper extremity injuries. Pediatr Clin North Am 2006; 53:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11609/abstract/14\">",
"      Kocher MS, Waters PM, Micheli LJ. Upper extremity injuries in the paediatric athlete. Sports Med 2000; 30:117.",
"     </a>",
"    </li>",
"    <li>",
"     Merrill's Atlas of Radiographic Positions and Radiologic Procedures, 10th, Ballinger PW, Frank ED.  (Eds), Mosby, St. Louis 2003. Vol 1.",
"    </li>",
"    <li>",
"     Flynn JM, Skaggs DL, Waters PM. Staying out of trouble while treating hand, wrist, and forearm injury. In: Staying Out of Trouble in Pediatric Orthopaedics, Skaggs DL, Flynn JM.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.85.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11609/abstract/17\">",
"      Mabrey JD, Fitch RD. Plastic deformation in pediatric fractures: mechanism and treatment. J Pediatr Orthop 1989; 9:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11609/abstract/18\">",
"      Schwarz N, Pienaar S, Schwarz AF, et al. Refracture of the forearm in children. J Bone Joint Surg Br 1996; 78:740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11609/abstract/19\">",
"      Gruber R, von Laer LR. [The etiology of the refracture of the forearm in childhood (author's transl)]. Aktuelle Traumatol 1979; 9:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11609/abstract/20\">",
"      Park HW, Yang IH, Joo SY, et al. Refractures of the upper extremity in children. Yonsei Med J 2007; 48:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11609/abstract/21\">",
"      Davis DR, Green DP. Forearm fractures in children: pitfalls and complications. Clin Orthop Relat Res 1976; :172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11609/abstract/22\">",
"      Sharieff GQ, Kanegaye J, Wallace CD, et al. Can portable bedside fluoroscopy replace standard, postreduction radiographs in the management of pediatric fractures? Pediatr Emerg Care 1999; 15:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11609/abstract/23\">",
"      Drendel AL, Gorelick MH, Weisman SJ, et al. A randomized clinical trial of ibuprofen versus acetaminophen with codeine for acute pediatric arm fracture pain. Ann Emerg Med 2009; 54:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11609/abstract/24\">",
"      Chess DG, Hyndman JC, Leahey JL, et al. Short arm plaster cast for distal pediatric forearm fractures. J Pediatr Orthop 1994; 14:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11609/abstract/25\">",
"      Bould M, Bannister GC. Refractures of the radius and ulna in children. Injury 1999; 30:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11609/abstract/26\">",
"      Deluca PA, Lindsey RW, Ruwe PA. Refracture of bones of the forearm after the removal of compression plates. J Bone Joint Surg Am 1988; 70:1372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11609/abstract/27\">",
"      Shoemaker SD, Comstock CP, Mubarak SJ, et al. Intramedullary Kirschner wire fixation of open or unstable forearm fractures in children. J Pediatr Orthop 1999; 19:329.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6538 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-202.43.93.2-481E12C6DB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_21_11609=[""].join("\n");
var outline_f11_21_11609=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H36\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PERTINENT ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MECHANISM OF INJURY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PHYSICAL FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Inspection and palpation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Neurovascular examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Acute compartment syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Associated injuries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      RADIOGRAPHIC FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Radiographic technique",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Radiographic views",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Classification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Specific fractures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Plastic deformations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Greenstick fractures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Complete fractures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Comminuted fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Associated fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      INITIAL TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Absent pulse",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Compartment syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Analgesia and splinting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      INDICATIONS FOR ORTHOPEDIC CONSULTATION OR REFERRAL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      DEFINITIVE CARE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Plastic deformation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Greenstick fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Complete fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Comminuted fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Immobilization and casting basics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      FOLLOW-UP CARE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Home pain management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6538\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6538|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?32/31/33279\" title=\"diagnostic image 1\">",
"      Greenstick and complete fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?17/59/18353\" title=\"diagnostic image 2\">",
"      Open midshaft fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?30/1/30750\" title=\"diagnostic image 3\">",
"      AP forearm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?25/32/26126\" title=\"diagnostic image 4\">",
"      Lateral forearm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?30/22/31072\" title=\"diagnostic image 5\">",
"      Forearm bowing fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?25/63/26608\" title=\"diagnostic image 6\">",
"      Midshaft greenstick fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?41/47/42750\" title=\"diagnostic image 7\">",
"      Midshaft greenstick fracture 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?4/57/5009\" title=\"diagnostic image 8\">",
"      Unstable midshaft fracture 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?30/55/31601\" title=\"diagnostic image 9\">",
"      Bowing and greenstick fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?9/8/9344\" title=\"diagnostic image 10\">",
"      Ulnar bowing 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?13/46/14050\" title=\"diagnostic image 11\">",
"      Complete midshaft forearm fracture 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?5/9/5266\" title=\"diagnostic image 12\">",
"      Unstable midshaft fracture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6538|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?23/13/23760\" title=\"figure 1\">",
"      Forearm anatomy 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?36/52/37698\" title=\"figure 2\">",
"      Radius ulna anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?23/56/24463\" title=\"figure 3\">",
"      Ulnar nerve test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/7/14463\" title=\"figure 4\">",
"      Thumbs up sign",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/55/17266\" title=\"figure 5\">",
"      Greenstick mechanism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?36/26/37281\" title=\"figure 6\">",
"      Distal sugar tong splint",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?30/59/31679\" title=\"figure 7\">",
"      Bowing fracture reduction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/46/16096\" title=\"figure 8\">",
"      Three point cast molding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6538|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/33/26142\" title=\"picture 1\">",
"      OK sign to assess median nerve",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6538|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/42/684\" title=\"table 1\">",
"      High risk trauma mechanisms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/11/24763\" title=\"table 2\">",
"      Elbow sensation strength",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/57/8090?source=related_link\">",
"      Acute compartment syndrome of the extremities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/11/40119?source=related_link\">",
"      Approach to the initially stable child with blunt or penetrating injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/56/37768?source=related_link\">",
"      Complex regional pain syndrome in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/15/44280?source=related_link\">",
"      Evaluation and management of pain in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/22/25961?source=related_link\">",
"      Evaluation and management of supracondylar fractures in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/23/1400?source=related_link\">",
"      General principles of definitive fracture management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/58/43941?source=related_link\">",
"      General principles of fracture management: Bone healing and fracture description",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20104?source=related_link\">",
"      General principles of fracture management: Fracture patterns and description in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/14/14569?source=related_link\">",
"      Initial management of distal forearm fractures in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/13/30934?source=related_link\">",
"      Midshaft humeral fractures in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/30/13802?source=related_link\">",
"      Orthopedic aspects of child abuse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?25/21/25937?source=related_link\">",
"      Patient information: Cast and splint care (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?10/51/11058?source=related_link\">",
"      Patient information: Cast and splint care (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/23/43384?source=related_link\">",
"      Procedural sedation in children outside of the operating room",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/54/15208?source=related_link\">",
"      Splinting of musculoskeletal injuries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/16/29962?source=related_link\">",
"      Trauma management: Approach to the unstable child",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_21_11610="Noninvasive methods for measurement of left ventricular systolic function";
var content_f11_21_11610=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Noninvasive methods for measurement of left ventricular systolic function",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/21/11610/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/21/11610/contributors\">",
"     Peter G Danias, MD, PhD, FACC, FESC",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/21/11610/contributors\">",
"     Gary V Heller, MD, PhD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/21/11610/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/21/11610/contributors\">",
"     Warren J Manning, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/21/11610/contributors\">",
"     Wilson S Colucci, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/21/11610/contributors\">",
"     Jeroen J Bax, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/21/11610/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/21/11610/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/21/11610/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/21/11610/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients with left ventricular (LV) systolic dysfunction, prognosis varies inversely with the left ventricular ejection fraction (LVEF). The LVEF is a key criterion for treatment options in patients with heart failure",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    valvular heart disease. As a result, measurement of LVEF is a common procedure in patients with heart disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/48/33546?source=see_link&amp;anchor=H4#H4\">",
"     \"Predictors of survival in heart failure due to systolic dysfunction\", section on 'Left ventricular ejection fraction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    LV systolic function is usually assessed by the resting left ventricular ejection fraction (LVEF). In addition to resting LV function, both the absolute value of exercise LVEF and exercise-induced change from resting LVEF have prognostic implications (",
"    <a class=\"graphic graphic_figure graphicRef53201 \" href=\"UTD.htm?4/49/4894\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. However, it is unclear in the reperfusion era if the exercise value provides appreciable prognostic information beyond the resting value in patients with acute myocardial infarction [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/24/20874?source=see_link\">",
"     \"Incidence of and risk stratification for sudden cardiac death after acute myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The LVEF is expressed as the ratio of the stroke volume divided by the end-diastolic volume and is calculated as follows.",
"   </p>",
"   <p>",
"    &nbsp;Stroke volume (SV) &nbsp;= &nbsp;LV end-diastolic volume &nbsp;- &nbsp;LV end-systolic volume",
"   </p>",
"   <p>",
"    &nbsp;LVEF, percent &nbsp;= &nbsp;(SV &nbsp;&divide; &nbsp;LV end-diastolic volume) &nbsp;x &nbsp;100",
"   </p>",
"   <p>",
"    Measurement of left ventricular ejection fraction (LVEF) is now generally performed using noninvasive methods. As an example, the American Heart",
"    <span class=\"nowrap\">",
"     Association/American",
"    </span>",
"    College of Cardiology",
"    <span class=\"nowrap\">",
"     (AHA/ACC)",
"    </span>",
"    guidelines on patients with chronic stable angina include recommendations on the noninvasive measurement of LV function (",
"    <a class=\"graphic graphic_table graphicRef63452 \" href=\"UTD.htm?19/10/19628\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/6\">",
"     6",
"    </a>",
"    ]. Although invasive methods, such as single plane or even biplane contrast left ventriculography, have been widely used and are validated for accuracy in assessing LVEF, noninvasive techniques can provide the same information without the associated procedural risks. In addition, some noninvasive approaches have better accuracy and reproducibility of LVEF measurements than the invasive techniques.",
"   </p>",
"   <p>",
"    This discussion will review the advantages and disadvantages of five noninvasive modalities used to evaluate quantify LVEF and evaluate ventricular wall motion:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Radionuclide ventriculography",
"     </li>",
"     <li>",
"      Echocardiography, both two-dimensional and three-dimensional",
"     </li>",
"     <li>",
"      Gated single photon emission tomography",
"     </li>",
"     <li>",
"      Cardiovascular magnetic resonance imaging.",
"     </li>",
"     <li>",
"      Computed tomography",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This will be followed by a set of recommendations of which test might be preferred in particular clinical settings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     RADIONUCLIDE VENTRICULOGRAPHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of synonyms have been used to describe radionuclide ventriculography (RVG). These include radionuclide angiography (RNA), radionuclide cine angiography (RNCA), multiple gated cardiac blood pool imaging (MUGA), and equilibrium radionuclide angiography (ERNA).",
"   </p>",
"   <p>",
"    RVG was first introduced in the early 1970s and quickly became accepted as the preferred technique for measurement of LVEF with a high degree of accuracy. Several early studies demonstrated an excellent correlation of RVG-derived LVEF with values obtained by cardiac catheterization contrast ventriculography (r = 0.94) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/7-10\">",
"     7-10",
"    </a>",
"    ]. Advantages of RVG include high reproducibility and low inter- and intra-observer variability (less than 5 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/11-14\">",
"     11-14",
"    </a>",
"    ]. RVG and cardiovascular magnetic resonance are considered the most reproducible tests for the assessment of LV systolic function. (See",
"    <a class=\"local\" href=\"#H27\">",
"     'Cardiovascular magnetic resonance imaging'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The RVG is performed by labeling the patient's red blood pool with a radioactive tracer and measuring radioactivity over the anterior chest, with a suitably positioned gamma camera, as the radioactive (labeled) blood flows through the large vessels and heart. The number of counts recorded at any time is proportional to the amount of the blood radioactivity, which is linearly related to the blood volume close to the detecting equipment. Thus, a direct volumetric assessment of the cardiac chambers throughout the cardiac cycle can be performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Blood pool labeling",
"    </span>",
"    &nbsp;&mdash;&nbsp;The blood pool is labeled with technetium 99m (Tc-99m), which has the advantages of short half-life (six hours), ideal imaging characteristics, and high rates of binding to red blood cells. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/23/35192?source=see_link\">",
"     \"Basic properties of myocardial perfusion agents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Labeling is usually performed either in vitro by incubating a small autologous blood sample with Tc-99m or in vivo with the direct intravenous injection of Tc-99m pertechnetate [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/15\">",
"     15",
"    </a>",
"    ]. The in vivo labeling technique is more convenient for the majority of patients since it involves one venipuncture instead of two and is less time-consuming and less costly. Although red blood cell binding of the radioactive tracer is generally more efficient with the in vitro techniques, more than 80 percent of the injected radionuclide usually binds to red cells with the in vivo approach.",
"   </p>",
"   <p>",
"    There is, however, one setting in which the in vitro labeling approach is preferred: in patients with long, indwelling, intravenous catheters. Unbound Tc-99m avidly adheres to the catheter wall, thereby decreasing the efficiency of blood pool labeling and severely reducing the image quality.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Equilibrium RVG",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two applications of RVG are currently used, equilibrium and first-pass. With equilibrium RVG, radioactivity data are accumulated over a 5- to 10-minute period, involving 800 to 1000 heart beats, depending upon the heart rate. Measurement of counts is gated to the cardiac cycle, which involves dividing the RR interval into 16 to 32 equal phases (gating windows) and separately recording counts for each window over the duration of the acquisition. Anterior, left anterior oblique (LAO), and left posterior oblique (LPO) projections are generally obtained to best visualize different cardiac structures and LV walls (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef59840 \" href=\"UTD.htm?43/41/44693\">",
"     image 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The anterior projection provides information about right atrial (RA) and right ventricular (RV) size and function, and regional systolic function of the anterolateral LV wall and apex.",
"     </li>",
"     <li>",
"      The LPO projection visualizes the inferior, apical, and anterolateral LV walls.",
"     </li>",
"     <li>",
"      The LAO projection separates RV and LV, and identifies septal, anterolateral, and posterolateral LV wall motion. Cranial LAO orientation (frequently achieved with slanted collimators) offers additional separation of the left atrium (LA) from the LV.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For measurement of LVEF, the LAO projection best separates the right and left ventricles and provides the best definition of the LV contour (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef59840 \" href=\"UTD.htm?43/41/44693\">",
"     image 1",
"    </a>",
"    ). Nuclear medicine technologists learn how to position the gamma camera in the LAO position that maximizes LV-RV separation (modified [m] LAO).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Advantages",
"    </span>",
"    &nbsp;&mdash;&nbsp;The equilibrium RVG has several advantages for LVEF measurement:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      High accuracy and reproducibility.",
"     </li>",
"     <li>",
"      Measurements do not rely on geometric assumptions regarding the shape of the LV.",
"     </li>",
"     <li>",
"      Global and regional LV systolic function can be assessed.",
"     </li>",
"     <li>",
"      Functional information for all cardiac chambers (both atria and ventricles) is readily available.",
"     </li>",
"     <li>",
"      Phase analysis of segmental ventricular contraction conveys information for regional dyssynergy.",
"     </li>",
"     <li>",
"      The technique can be used for accurate volumetric measurements with the use of an appropriate phantom and corrections for soft tissue attenuation [",
"      <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The patient's body habitus does not limit the technique and virtually all patients can be imaged.",
"     </li>",
"     <li>",
"      The noninvasive nature of the test minimizes associated risks.",
"     </li>",
"     <li>",
"      RVG is easy to perform and not time consuming (less than 30 minutes).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Limitations",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several limitations with equilibrium RVG:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The uniform whole body radiation exposure is 620 mrem (6.2 mSv) approximately twice the amount of natural environmental radiation the average person receives in the United States. Nevertheless, the test is contraindicated for pregnant or lactating women.",
"     </li>",
"     <li>",
"      Obtaining the optimum projection for separation of RV and LV and defining regions of interest by tracing contours of ventricular cavities (when manual techniques are used), are both operator-dependent. Thus, bad technique can introduce errors in measurement.",
"     </li>",
"     <li>",
"      The test provides limited information regarding the anatomic structure of the cardiac chambers and minimal information about valvular structure and function.",
"     </li>",
"     <li>",
"      With the exception of the intraventricular septum, ventricular wall thickness cannot be assessed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    ECG gating becomes unreliable in patients with arrhythmias and significant variability of the RR interval. Modified acquisition and postprocessing methods, such as \"list mode acquisition,\" have been implemented and are clinically used to correct for RR variability [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/17-21\">",
"     17-21",
"    </a>",
"    ]. With this approach the frequency distribution of the RR interval is plotted for the duration of acquisition; the operator can then select a narrow range for acceptance around the mode of distribution to retrospectively minimize variability. However, even with such approaches, RVG cannot be reliably performed in the presence of marked arrhythmias.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     First-pass RVG",
"    </span>",
"    &nbsp;&mdash;&nbsp;In contrast to equilibrium RVG, first-pass RVG measures systolic cardiac function for only a few heart beats, usually 6 to 10, immediately following bolus intravenous injection of the radionuclide. In the conventional first-pass RVG, the acquisition is not gated; instead, measurement and recording are performed continuously for successive 0.5 second periods. Thus, the radioactive bolus is monitored continuously as it passes for the first time through the right atrium, ventricle, lungs, and then left atrium and ventricle (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef60808 \" href=\"UTD.htm?7/17/7442\">",
"     image 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    First-pass RVG allows accurate quantitation of right and left ventricular function and regurgitant valvular lesions and of right and left sided cardiac outputs. The RAO projection is used for data acquisition since it permits the best separation of the atria from the ventricles. Although this projection has maximal ventricular overlap, this is not a particular problem as a time separation of ventricular activity occurs following bolus injection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Advantages",
"    </span>",
"    &nbsp;&mdash;&nbsp;First-pass RVG offers additional benefits to those listed for equilibrium RVG: (see",
"    <a class=\"local\" href=\"#H5\">",
"     'Advantages'",
"    </a>",
"    above)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      High target-to-background ratio",
"     </li>",
"     <li>",
"      Rapid imaging",
"     </li>",
"     <li>",
"      Accurate measurement of both right and left ventricular ejection fraction",
"     </li>",
"     <li>",
"      Evaluation and quantification of intracardiac shunts and regurgitant valvular lesions",
"     </li>",
"     <li>",
"      Quantification of the pulmonary transit time, ie, the time that it takes for the blood to circulate through the pulmonary vasculature, which can be used for measurement of the pulmonary blood volume if the cardiac output is known",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, when combined with exercise or pharmacologic stress, first-pass RVG can assess changes in the systolic performance of the left ventricle with exercise. As a result, exercise-RVG can provide useful information regarding the severity of coronary artery disease and myocardial viability and can assess prognosis in patients with coronary disease [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/2,4,22\">",
"     2,4,22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Limitations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since only the anterior projection is acquired for first-pass RVG studies, this technique has limited value for the assessment of regional ventricular function. To overcome this problem, equilibrium acquisition usually follows the first-pass to evaluate regional wall function. Another limitation is that, with first-pass RVG, it is impractical for more than three determinations at one time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Combined first-pass RVG and SPECT perfusion imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Technical improvements in gamma camera equipment have allowed first-pass studies of ventricular function to be performed simultaneously with SPECT perfusion imaging. For this approach ECG-gating is usually combined with list-mode acquisition and high count statistics are obtained [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/18,23-31\">",
"     18,23-31",
"    </a>",
"    ]. This methodology offers the potential advantage of measuring a \"true\" exercise ejection fraction, compared with the resting or post exercise measurement obtained with gated SPECT (see",
"    <a class=\"local\" href=\"#H23\">",
"     'Gated single photon emission tomography'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     ECHOCARDIOGRAPHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two dimensional (2D) echocardiography allows real-time imaging of the heart and its various structures using ultrasonic waves. With the ultrasound beam directed perpendicularly to the myocardium, wall motion and thickening can easily be detected on the imaging plane. Several imaging windows, including parasternal, apical, and subcostal views, are used to visualize all ventricular walls (",
"    <a class=\"graphic graphic_figure graphicRef68362 \" href=\"UTD.htm?6/36/6722\">",
"     figure 2",
"    </a>",
"    ). Three dimensional (3D) echocardiographic images are generated by integration of information from multiple 2D imaging planes. (See",
"    <a class=\"local\" href=\"#H22\">",
"     'Three dimensional echocardiography'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/38/23146?source=see_link\">",
"     \"Three-dimensional echocardiography\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The introduction of harmonic imaging and the use of echocardiographic contrast media for improved endocardial border definition have significantly improved image quality, thereby enhancing the accuracy of assessment of the left LVEF, particularly in patients with poor acoustic windows [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/32-35\">",
"     32-35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/53/13145?source=see_link\">",
"     \"Contrast echocardiography: Clinical applications\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Estimation of the LVEF by 2D echocardiography can be done either qualitatively by visual inspection of global and regional function or quantitatively, using geometric assumptions regarding the shape of the LV cavity. Simplified analyses have been developed and are currently used to facilitate the acquisition of important indices. Global and regional LV systolic function can both be accurately assessed by experienced readers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Qualitative global function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Global function is typically described as normal, depressed, or hyperdynamic.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Depressed systolic function may be characterized both by severity (mild, moderate, severe) and focality (global or regional).",
"     </li>",
"     <li>",
"      Hyperdynamic function is frequently associated with high-output syndromes (eg, anemia, thyrotoxicosis), hypertrophic cardiomyopathies, or in response to exercise or pharmacologic stress (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The visual assessment of global LVEF is typically reported in intervals of 5 or 10 percent and within a range (eg, 35 to 40 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Qualitative regional function",
"    </span>",
"    &nbsp;&mdash;&nbsp;The regional assessment of LV systolic function is assessed by dividing the entire left ventricle into segments. For the purposes of localizing segmental wall motion abnormalities in a standardized format, the American Society of Echocardiography (ASE) has recommended dividing the ventricle into 16 segments (",
"    <a class=\"graphic graphic_figure graphicRef55855 \" href=\"UTD.htm?1/21/1360\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/36\">",
"     36",
"    </a>",
"    ]. The American Heart Association (AHA), as part of an effort to unify wall motion analysis among different imaging modalities, concluded that a 17 segment model was preferred (",
"    <a class=\"graphic graphic_figure graphicRef64968 \" href=\"UTD.htm?25/55/26487\">",
"     figure 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/37\">",
"     37",
"    </a>",
"    ]. Most centers have migrated to this 17-segment model.",
"   </p>",
"   <p>",
"    A score is then assigned to each segment:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      0 = normal",
"     </li>",
"     <li>",
"      1 = hypokinesis",
"     </li>",
"     <li>",
"      2 = akinesis",
"     </li>",
"     <li>",
"      3 = dyskinesis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The total score (0 = normal) permits a semiquantitative assessment of left ventricular systolic function.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Quantitative evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although qualitative assessments are more widely used in clinical practice, echocardiography can also generate a number of quantitative assessments of LV size and function. Quantitative measurements are available for uni-dimensional (M-mode), two-dimensional (2D), and three-dimensional (3D) techniques.",
"   </p>",
"   <p>",
"    The linear measurement estimations of ventricular volumes and ejection fraction assume that the left ventricle can be described by the revolution of a prolate ellipse. Thus, the ventricular volume is approximately D",
"    <sup>",
"     3",
"    </sup>",
"    , where D is the short-axis diameter of the left ventricle at the tips of the mitral valve (&ldquo;cube formula&rdquo;).",
"   </p>",
"   <p>",
"    Two-dimensional estimations of left ventricular function can be performed based on the assumption that the left ventricle has the shape of a truncated-ellipsoid (&ldquo;area-length&rdquo; or &ldquo;bullet&rdquo; formula). The method of discs (Simpson&rsquo;s rule) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef72326 \" href=\"UTD.htm?18/34/18982\">",
"     image 3",
"    </a>",
"    ) and the method of multiple diameters generally provide more accurate measurements of ventricular volumes and ejection fraction than the linear (M-mode) techniques, and are the recommended techniques for transthoracic quantitative evaluations [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/38,39\">",
"     38,39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    With 3D echocardiography, a polyhedral surface reconstruction algorithm can be used to more accurately represent the geometry of the left ventricle and quantify measures of systolic function. Systems for automated comprehensive quantitative assessment of the entire left ventricle have been developed but have limited availability.",
"   </p>",
"   <p>",
"    Speckle-tracking has evolved as a method to mark small segments of the myocardium and track their motion throughout the cardiac cycle, thereby allowing to measure not only the systolic shortening but also the rotation of the left ventricle and stress-strain of the myocardium in the circumferential and longitudinal directions [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/40\">",
"     40",
"    </a>",
"    ]. With echocardiography, quantitative indexes of ventricular volumes, ventricular mass, and wall stress can be derived [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The study of cardiac mechanics is an evolving field of investigation in echocardiography [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/41\">",
"     41",
"    </a>",
"    ]. The use of echocardiography as a potential tool to assess candidates for cardiac resynchronization is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/56/18314?source=see_link\">",
"     \"Cardiac resynchronization therapy in heart failure: Indications\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Assessment of myocardial strain and strain-rate",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term \"strain\" refers to an object's fractional or percentage change from its original, unstressed, dimension (ie, a change in length corrected for the original length) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. It reflects deformation of a structure, and when applied to the myocardium, strain directly describes the",
"    <span class=\"nowrap\">",
"     contraction/relaxation",
"    </span>",
"    pattern. Strain can be calculated in several dimensions; longitudinal, circumferential, or radial [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/43\">",
"     43",
"    </a>",
"    ]. Strain rate is the rate of this deformation [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Myocardial strain has been measured with cardiovascular magnetic resonance imaging, two-dimensional echo, tissue Doppler and speckle-tracking imaging. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/3/34874?source=see_link\">",
"     \"Clinical utility of cardiovascular magnetic resonance imaging\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/45/7897?source=see_link&amp;anchor=H7#H7\">",
"     \"Tissue Doppler echocardiography\", section on 'Strain and strain rate imaging'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite the promise that strain and strain rate imaging offer, a number of challenges limit clinical utility, including [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/43\">",
"     43",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Complex methodology",
"     </li>",
"     <li>",
"      Technical challenges of image acquisition",
"     </li>",
"     <li>",
"      Susceptibility to artifact",
"     </li>",
"     <li>",
"      Lack of consensus regarding optimal methods and parameters",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Accuracy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of studies have evaluated the accuracy of 2D echocardiography for measurement of LVEF compared to RVG",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    contrast ventriculography [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/38,44,45\">",
"     38,44,45",
"    </a>",
"    ]. In a review of published studies, it was concluded that the three techniques exhibited a high correlation but only moderate agreement [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/44\">",
"     44",
"    </a>",
"    ]. As will be described, three-dimensional echocardiography provides values comparable to RVG that may be superior to 2D echocardiographic measurements [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/46\">",
"     46",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H22\">",
"     'Three dimensional echocardiography'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Advantages",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two-dimensional echocardiography offers the following advantages:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It is noninvasive and does not involve radiation. The vast majority of patients do not require intravenous access or use of an exogenous contrast agent.",
"     </li>",
"     <li>",
"      Current equipment allows easy portable (eg, bedside) studies at relatively low cost.",
"     </li>",
"     <li>",
"      It accurately evaluates regional wall motion, which is of particular importance in assessing patients with coronary disease.",
"     </li>",
"     <li>",
"      Various indices of diastolic LV function (isovolumic relaxation time, deceleration time, E to A wave ratio, etc) can be reproducibly measured with echocardiography. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/22/43368?source=see_link\">",
"       \"Clinical manifestations and diagnosis of diastolic heart failure\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      All other cardiac structures, including valves, can be visualized, and the anatomic and functional integrity can be thoroughly evaluated. The additive information of Doppler echocardiography may be of fundamental importance. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/0/15365?source=see_link\">",
"       \"Principles of Doppler echocardiography\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Echocardiography is not limited by arrhythmias, because it is an inherently real-time imaging technique. However, ventricular function may be adversely affected by the arrhythmia.",
"     </li>",
"     <li>",
"      As with RVG, echocardiography can be used in conjunction with exercise or pharmacologic stressing, to evaluate stress-induced ischemia. Wall thickening can also be used to assess myocardial viability. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27466?source=see_link\">",
"       \"Stress echocardiography in the diagnosis and prognosis of coronary heart disease\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Disadvantages",
"    </span>",
"    &nbsp;&mdash;&nbsp;2D echocardiography has several disadvantages:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Accuracy may be limited by geometric assumptions regarding the shape of the left ventricular cavity.",
"     </li>",
"     <li>",
"      It requires an experienced sonographer and echocardiographer. A variety of artifacts can be generated by improper positioning of the imaging transducer or incorrect setting of the equipment's gain controls.",
"     </li>",
"     <li>",
"      Although interpretation by an experienced reader is reproducible, this is not the case with more novice readers. Even in the best of hands, the interobserver and intraobserver variability are in the range 10 to 30 percent, clearly greater than those seen with RVG or cardiovascular magnetic resonance.",
"     </li>",
"     <li>",
"      Although quantitative approaches are generally more accurate than qualitative assessment, such methods are time consuming and rely on assumptions regarding the LV shape.",
"     </li>",
"     <li>",
"      The diagnostic value of echocardiography is limited in patients with poor acoustic windows, such as obese individuals, patients with hyperinflated lungs (eg, due to obstructive or other lung diseases), patients with musculoskeletal deformities (eg, kyphosis, pectus excavatum), or patients that cannot be properly positioned for a thorough study (eg, postoperative).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Three dimensional echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;3D echocardiography appears to produce LVEF values similar to RVG and cardiovascular magnetic resonance, and offers incremental benefit over 2D techniques and improved accuracy and reproducibility (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef50015 \" href=\"UTD.htm?15/47/16115\">",
"     image 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/46-50\">",
"     46-50",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/38/23146?source=see_link&amp;anchor=H3#H3\">",
"     \"Three-dimensional echocardiography\", section on 'Assessment of left ventricular volume and function'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One study, for example, compared LVEF measurements obtained by 3D echocardiography, quantitative and qualitative 2D echocardiography, and RVG in 51 patients with heart disease; there was an excellent correlation between 3D echocardiography and RVG (r = 0.94 to 0.97) without significant overestimation or underestimation [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/46\">",
"     46",
"    </a>",
"    ]. 3D echocardiography was superior to both quantitative and qualitative 2D echocardiographic techniques. In other studies, 3D echocardiography correlated well with measurements made using cardiac magnetic resonance imaging [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/48-52\">",
"     48-52",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H27\">",
"     'Cardiovascular magnetic resonance imaging'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    3D echocardiography has also been investigated as a tool to quantify LV dyssynchrony in patients being considered for cardiac resynchronization therapy (biventricular pacing). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/56/18314?source=see_link\">",
"     \"Cardiac resynchronization therapy in heart failure: Indications\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     GATED SINGLE PHOTON EMISSION TOMOGRAPHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The application of ECG-gating for single photon emission tomography (SPECT) radionuclide myocardial perfusion imaging permits segmentation of the cardiac cycle in several phases and data for each can be acquired separately [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/53-58\">",
"     53-58",
"    </a>",
"    ]. SPECT is based upon the flow-dependent",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    metabolism-dependent selective uptake of a radioactive tracer by functional myocardial tissue. This method was developed to evaluate myocardial perfusion and viability and is applied both at rest and after exercise or pharmacologic stress to assess provocable ischemia due to flow limiting coronary stenoses. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/33/23066?source=see_link\">",
"     \"Assessment of myocardial viability by nuclear imaging in coronary heart disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/24/24970?source=see_link\">",
"     \"Exercise radionuclide myocardial perfusion imaging in the diagnosis and prognosis of coronary heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Using gated image acquisition with the appropriate computer hardware and software, a series of consecutive frames within each gating window can be reconstructed for each slice and displayed as a continuous loop. Automatic border detection can also be used to reconstruct the LV endocardial and epicardial surfaces. These surfaces can also be displayed dynamically in a cine loop, allowing better appreciation of the ventricular shape and regional contractility.",
"   </p>",
"   <p>",
"    ECG-gated acquisition is generally performed with a technetium-99m based agent because of high count statistics, although thallium-201 can also be used. LVEF can then be determined either qualitatively by visual inspection or automatically with the introduction of quantitative gated SPECT algorithms [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/59,60\">",
"     59,60",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Accuracy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The accuracy of LVEF assessment by ECG-gated SPECT has been validated against both echocardiography and RVG [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/55,59,61\">",
"     55,59,61",
"    </a>",
"    ]. In one study of 54 patients, for example, LVEF values obtained from gated SPECT imaging were compared to those obtained by first-pass RVG and contrast ventriculography [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/55\">",
"     55",
"    </a>",
"    ]. The values from SPECT imaging were slightly, but significantly, lower (by 2.7 EF units) than those obtained from contrast ventriculography. However, there was an excellent correlation between SPECT and contrast ventriculographic ejection fractions (r = 0.93) over a wide range of ejection fractions (14 to 89 percent). First-pass RVG LVEF values were even lower (8 EF units) than those obtained with contrast ventriculography, but correlated well with data from the gated SPECT (r = 0.87) and contrast ventriculography (r = 0.83). The reproducibility rates for gated SPECT imaging were excellent (intraobserver r = 0.99, interobserver r = 0.93).",
"   </p>",
"   <p>",
"    The accuracy of ECG-gated SPECT for calculation of left ventricular volumes and LVEF has also been compared to cardiac magnetic resonance imaging. A meta-analysis of all relevant studies in humans demonstrated that data by ECG-gated SPECT correlated closely (R2 = 0.75 to 0.85) with the MRI data over a wide range of ventricular volumes and ejection fractions [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Advantages",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gated SPECT techniques offer the following advantages:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Simultaneous assessment of ventricular perfusion and function. This may be cost-efficient in the cardiac work-up of patients with known or suspected coronary disease since other functional tests may not be necessary and does not expose the patient to \"additional\" radiation.",
"     </li>",
"     <li>",
"      Improved diagnostic accuracy of radionuclide myocardial perfusion imaging (",
"      <a class=\"graphic graphic_figure graphicRef63493 \" href=\"UTD.htm?33/26/34221\">",
"       figure 5",
"      </a>",
"      ). Fixed defects with both stress and rest may be classified as attenuation artifact if regional wall thickening and motion (determined by gated techniques) are normal [",
"      <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/63,64\">",
"       63,64",
"      </a>",
"      ]. Such classification improves specificity by 10 to 15 percent.",
"     </li>",
"     <li>",
"      Evaluation of resting and post-stress global and regional wall motion and thickening.",
"     </li>",
"     <li>",
"      Evaluation of myocardial viability, with simultaneous evaluation of regional perfusion and wall motion. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/41/10905?source=see_link\">",
"       \"Evaluation of hibernating myocardium\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Classification of patients with nonischemic and ischemic dilated cardiomyopathies [",
"      <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/65,66\">",
"       65,66",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The technique is generally not limited by the patients' body habitus.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Disadvantages",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are only a few disadvantages of gated SPECT imaging:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It requires a regular rhythm in order for ECG-gating to be reliably performed.",
"     </li>",
"     <li>",
"      In regions of the myocardium with fewer counts due to ischemia, previous infarction, or attenuation, the wall motion and thickening may be underestimated. Newer methods which enhance visualization of hypoperfused segments are being evaluated for regional wall motion assessment [",
"      <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/67\">",
"       67",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      It involves radiation exposure to the patient of similar magnitude to the RVG, but not increased compared to a perfusion-only study.",
"     </li>",
"     <li>",
"      It reflects only resting ventricular function and cannot be performed at peak stress.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26431337\">",
"    <span class=\"h2\">",
"     ECG gated PET imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;An alternative to stress SPECT imaging is cardiac positron emission tomography (PET) perfusion imaging. PET perfusion imaging offers higher diagnostic accuracy, a very rapid protocol, and excellent image quality [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/68\">",
"     68",
"    </a>",
"    ]. Gated PET imaging can be performed in a similar method to SPECT gated imaging both at rest and stress, enabling assessment of reversible wall motion abnormalities, evaluation of regional and global left ventricular function, as well as risk stratification. Because of the proximity of acquisition of imaging data to that of hyperemic stress during vasodilator infusion, reversible wall motion abnormalities are more common. These findings are suggestive of more severe disease and a worse prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]. In addition, the presence of wall motion abnormalities and low ejection fraction carries a worse prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/71\">",
"     71",
"    </a>",
"    ]. Furthermore, the combination of low ejection fraction during gated PET imaging and perfusion abnormalities carries a worse prognosis. Thus, in patients undergoing PET perfusion imaging rather than SPECT, ventricular function assessment is similar with higher degree of reversible wall motion abnormalities. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     CARDIOVASCULAR MAGNETIC RESONANCE IMAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiovascular magnetic resonance imaging (CMRI) is an increasingly available diagnostic method. Among the significant advantages of CMRI technology is the very high spatial (0.5 mm) and temporal resolution of cine images. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/3/34874?source=see_link\">",
"     \"Clinical utility of cardiovascular magnetic resonance imaging\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For cardiac imaging, ECG-triggering and breath holding are frequently employed. \"True\" short axis images can be obtained to span the whole left ventricle. For assessment of ventricular function fast gradient-echo techniques are generally applied. Older &ldquo;conventional&rdquo; gradient echo techniques have been now replaced with steady-state free precession sequences that offer excellent contrast between cavity blood pool and myocardium. Accelerated image acquisition techniques allow for a complete volumetric data set to be obtained within a single breath-hold [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/72\">",
"     72",
"    </a>",
"    ]. For each slice, images of several sequential cardiac phases can be obtained and displayed as a cine loop that spans systole and diastole. The LVEF can then be accurately measured by applying Simpson's rule and tracing the systolic and diastolic endocardial borders of all slices and summing the corresponding volumes (volume &nbsp;= &nbsp;slice area &nbsp;x &nbsp;slice thickness). Thus, CMRI obviates the need for any geometric assumptions regarding the shape of the LV for determination of the EF value, as is necessary with 2D echocardiography.",
"   </p>",
"   <p>",
"    Since CMRI provides almost anatomic image quality by obtaining high quality tomographic images in any geometric plane, both experimental and human studies have shown that measurement of LV volumes is highly accurate and precise and is effective in both global and regional left ventricular dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/48-50,62,73-79\">",
"     48-50,62,73-79",
"    </a>",
"    ]. Thus, CMRI is the most accurate available noninvasive imaging technique for determination of LVEF, although three-dimensional echocardiography and RVG may provide similar results [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/48-50,76\">",
"     48-50,76",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Advantages",
"    </span>",
"    &nbsp;&mdash;&nbsp;CMRI has the following advantages:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      High spatial and temporal resolution",
"     </li>",
"     <li>",
"      Tomographic images can be obtained in any plane and any orientation",
"     </li>",
"     <li>",
"      Imaging is not limited by the patient's body habitus",
"     </li>",
"     <li>",
"      Comprehensive evaluation of virtually every aspect of the cardiac anatomy and function",
"     </li>",
"     <li>",
"      Absence of ionizing radiation exposure to patients and physicians (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/3/34874?source=see_link&amp;anchor=H4#H4\">",
"       \"Clinical utility of cardiovascular magnetic resonance imaging\", section on 'Safety'",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      No need for exogenous contrast agent",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Disadvantages",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite its many advantages, CMRI has certain disadvantages:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      CMRI technology is not as widely available.",
"     </li>",
"     <li>",
"      Currently available technology requires manual tracing of the endocardial borders; this increases the analysis time and may introduce observer bias",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Pacemakers/defibrillators",
"      </span>",
"      are relative contraindications for MR imaging (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/35/5689?source=see_link&amp;anchor=H20#H20\">",
"       \"Principles of magnetic resonance imaging\", section on 'Cardiovascular devices'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      It is currently not suitable for claustrophobic individuals",
"     </li>",
"     <li>",
"      Motion during imaging results in significant image artifacts",
"     </li>",
"     <li>",
"      Technology is not suitable for portable (eg, bedside) studies.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     COMPUTED TOMOGRAPHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Computed tomography (CT) has been used to assess LV systolic function, particularly at the time of coronary CT angiography. With the newer multi-detector CT scanners, an image of the entire heart can be acquired within 10 to 15 seconds, typically during a breath-hold to freeze respiratory motion. Retrospective ECG gating is typically performed and the heart can be reconstructed at several time points within the cardiac cycle. The temporal resolution with the 16-detector systems was in the order of 100ms, while with the newer 64-detector systems, temporal resolution has decreased to ~85ms [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/80,81\">",
"     80,81",
"    </a>",
"    ]. The images are obtained in the transverse orientation, but, as CT can provide isotopic voxels due to inherently high spatial resolution, data can be reformatted in any orientation for analysis.",
"   </p>",
"   <p>",
"    The accuracy of multi-detector CT has been evaluated against MRI in several studies. The technique is very reproducible, as there is usually very good delineation of the endocardial border of all myocardial walls. Several studies suggested good agreement with cardiac MR measurements for LV and RV [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/80,82,83\">",
"     80,82,83",
"    </a>",
"    ]. Others, however, have cautioned that CT overestimates LV volumes, resulting in a small bias in the EF measurement [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/84\">",
"     84",
"    </a>",
"    ]. This is likely due to the relatively low temporal resolution of CT for a functional study. Regarding RV EF, one study showed suboptimal agreement between CT and MRI, mainly due to inadequate RV opacification [",
"    <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/83\">",
"     83",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is very unlikely that the CT will be used predominantly to measure ventricular volumes and ejection fraction, due to the associated significant radiation exposure. However, in patients undergoing CT coronary angiography, functional information comes \"for free\", at least with the current generation scanners that require continuous X-ray emission throughout the entire cardiac cycle. In these patients undergoing CT coronary angiography, it would be prudent to routinely quantify LVEF.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measurement of left ventricular ejection fraction (LVEF) is now generally performed using noninvasive methods. Although each of the five techniques described above can provide accurate information, each test has certain limitations that may be important in selected patients. Test selection also depends upon the indication for imaging:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      RVG or CMRI should be used for serial measurements of LVEF when even slight changes are of great importance, such as during chemotherapy, before and after heart transplantation, and severe heart failure. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/46/41706?source=see_link\">",
"       \"Cardiotoxicity of anthracycline-like chemotherapy agents\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/12/40138?source=see_link\">",
"       \"Cardiotoxicity of nonanthracycline cancer chemotherapy agents\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/24/28040?source=see_link\">",
"       \"Acute cardiac allograft rejection: Diagnosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/48/33546?source=see_link\">",
"       \"Predictors of survival in heart failure due to systolic dysfunction\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      2D echocardiography should be used for routine assessment of LVEF in patients with coronary disease and for evaluation of valvular function. However, RVG or CMRI should be performed if the echocardiographic image quality is suboptimal. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/49/24342?source=see_link\">",
"       \"Transthoracic echocardiography for the evaluation of chest pain in the emergency department\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Gated SPECT myocardial perfusion nuclear imaging is preferred for simultaneous assessment of myocardial perfusion and function. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/24/24970?source=see_link\">",
"       \"Exercise radionuclide myocardial perfusion imaging in the diagnosis and prognosis of coronary heart disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/33/23066?source=see_link\">",
"       \"Assessment of myocardial viability by nuclear imaging in coronary heart disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      CMRI, or RVG if CMRI is not available, is useful for research studies requiring high accuracy and reproducibility, permitting smaller sample size or increased statistical power.",
"     </li>",
"     <li>",
"      Quantitative echocardiography, cardiovascular magnetic resonance or radionuclide ventriculography should be used when critical management decisions depend upon the actual numeric value of the LVEF, such as when to place an implantable cardioverter-defibrillator, when to perform surgery in patients with asymptomatic mitral regurgitation, or whether chemotherapy is contraindicated in a patient with cancer [",
"      <a class=\"abstract\" href=\"UTD.htm?11/21/11610/abstract/85\">",
"       85",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These indications may change in the future, as advances in 3D echocardiography, multi-detector computed tomography, CMRI, and further refinements of gated SPECT imaging become less expensive and more widely available and as the experience acquired from such modalities expands and improves.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/1\">",
"      Shaw LJ, Heinle SK, Borges-Neto S, et al. Prognosis by measurements of left ventricular function during exercise. Duke Noninvasive Research Working Group. J Nucl Med 1998; 39:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/2\">",
"      Abraham RD, Harris PJ, Roubin GS, et al. Usefulness of ejection fraction response to exercise one month after acute myocardial infarction in predicting coronary anatomy and prognosis. Am J Cardiol 1987; 60:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/3\">",
"      Lee KL, Pryor DB, Pieper KS, et al. Prognostic value of radionuclide angiography in medically treated patients with coronary artery disease. A comparison with clinical and catheterization variables. Circulation 1990; 82:1705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/4\">",
"      Moriel M, Rozanski A, Klein J, et al. The differing prognostic utility of exercise radionuclide ventriculography in coronary artery disease patients with and without prior myocardial infarction. Int J Card Imaging 1997; 13:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/5\">",
"      Zaret BL, Wackers FJ, Terrin ML, et al. Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis in Myocardial Infarction (TIMI) phase II study. The TIMI Study Group. J Am Coll Cardiol 1995; 26:73.",
"     </a>",
"    </li>",
"    <li>",
"     Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina www.acc.org/qualityandscience/clinical/statements.htm (Accessed on August 24, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/7\">",
"      Burow RD, Strauss HW, Singleton R, et al. Analysis of left ventricular function from multiple gated acquisition cardiac blood pool imaging. Comparison to contrast angiography. Circulation 1977; 56:1024.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/8\">",
"      Folland ED, Hamilton GW, Larson SM, et al. The radionuclide ejection fraction: a comparison of three radionuclide techniques with contrast angiography. J Nucl Med 1977; 18:1159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/9\">",
"      Ashburn WL, Schelbert HR, Verba JW. Left ventricular ejection fraction--a review of several radionuclide angiographic approaches using the scintillation camera. Prog Cardiovasc Dis 1978; 20:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/10\">",
"      Schelbert HR, Verba JW, Johnson AD, et al. Nontraumatic determination of left ventricular ejection fraction by radionuclide angiocardiography. Circulation 1975; 51:902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/11\">",
"      Wackers FJ, Berger HJ, Johnstone DE, et al. Multiple gated cardiac blood pool imaging for left ventricular ejection fraction: validation of the technique and assessment of variability. Am J Cardiol 1979; 43:1159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/12\">",
"      Nichols K, Adatepe MH, Isaacs GH, et al. A new scintigraphic method for determining left ventricular volumes. Circulation 1984; 70:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/13\">",
"      Greenberg BH, Drew D, Botvinick EH, et al. Evaluation of left ventricular performance by gated radionuclide angiography. Clin Nucl Med 1980; 5:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/14\">",
"      Basilico FC, Folland ED, Karaffa S, et al. Non-invasive measurement of left ventricular function in coronary artery disease. Comparison of first pass radionuclide ventriculography, M-mode echocardiography, and systolic time intervals. Br Heart J 1981; 45:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/15\">",
"      Hegge FN, Hamilton GW, Larson SM, et al. Cardiac chamber imaging: a comparison of red blood cells labeled with Tc-99m in vitro and in vivo. J Nucl Med 1978; 19:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/16\">",
"      Warren SE, McKay RG, Aroesty JM, et al. Comparison of methods for determining absolute left ventricular volumes from radionuclide ventriculography. Am J Physiol Imaging 1987; 2:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/17\">",
"      Kuikka JT, Britton KE, Chengazi VU, Savolainen S. Future developments in nuclear medicine instrumentation: a review. Nucl Med Commun 1998; 19:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/18\">",
"      Vainio P, Jurvelin J, Kuikka J, et al. Analysis of left ventricular function from gated first-pass and multiple gated equilibrium acquisitions. Int J Card Imaging 1992; 8:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/19\">",
"      Lear JL, Pratt JP. Real-time list-mode processing of gated cardiac blood pool examinations with forward-backward framing. Eur J Nucl Med 1992; 19:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/20\">",
"      Vaquero JJ, Rahms H, Green MV, Del Pozo F. Dynamic circular buffering: a technique for equilibrium gated blood pool imaging. Comput Biol Med 1996; 26:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/21\">",
"      Vemmer T, Steinb&uuml;chel C, Bertram J, et al. Cardiac phase-synchronized myocardial thallium-201 single-photon emission tomography using list mode data acquisition and iterative tomographic reconstruction. Eur J Nucl Med 1997; 24:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/22\">",
"      Pancholy SB, Fattah AA, Kamal AM, et al. Independent and incremental prognostic value of exercise thallium single-photon emission computed tomographic imaging in women. J Nucl Cardiol 1995; 2:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/23\">",
"      Esquerr&eacute; JP, Coca FJ, Gantet P, Ouhayoun E. Feasibility of first-pass radionuclide angiocardiography with a 10-mCi technetium bolus using a single-crystal digital gamma camera: implications for technetium-sestamibi single-day protocols. Eur J Nucl Med 1995; 22:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/24\">",
"      Boucher CA, Wackers FJ, Zaret BL, Mena IG. Technetium-99m sestamibi myocardial imaging at rest for assessment of myocardial infarction and first-pass ejection fraction. Multicenter Cardiolite Study Group. Am J Cardiol 1992; 69:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/25\">",
"      Benari B, Kiat H, Erel J, et al. Repeatability of treadmill exercise ejection fraction and wall motion using technetium 99m-labeled sestamibi first-pass radionuclide ventriculography. J Nucl Cardiol 1995; 2:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/26\">",
"      Friedman JD, Berman DS, Kiat H, et al. Rest and treadmill exercise first-pass radionuclide ventriculography: validation of left ventricular ejection fraction measurements. J Nucl Cardiol 1994; 1:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/27\">",
"      Nichols K, DePuey EG, Rozanski A. First-pass radionuclide angiocardiography with single-crystal gamma cameras. J Nucl Cardiol 1997; 4:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/28\">",
"      Sciagr&agrave; R, Bisi G, Santoro GM, et al. Evaluation of coronary artery disease using technetium-99m-sestamibi first-pass and perfusion imaging with dipyridamole infusion. J Nucl Med 1994; 35:1254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/29\">",
"      Bisi G, Sciagr&agrave; R, B&uuml;ll U, et al. Assessment of ventricular function with first-pass radionuclide angiography using technetium 99m hexakis-2-methoxyisobutylisonitrile: a European multicentre study. Eur J Nucl Med 1991; 18:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/30\">",
"      Jones RH, Borges-Neto S, Potts JM. Simultaneous measurement of myocardial perfusion and ventricular function during exercise from a single injection of technetium-99m sestamibi in coronary artery disease. Am J Cardiol 1990; 66:68E.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/31\">",
"      Iskandrian AS, Heo J, Kong B, et al. Use of technetium-99m isonitrile (RP-30A) in assessing left ventricular perfusion and function at rest and during exercise in coronary artery disease, and comparison with coronary arteriography and exercise thallium-201 SPECT imaging. Am J Cardiol 1989; 64:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/32\">",
"      Thomson HL, Basmadjian AJ, Rainbird AJ, et al. Contrast echocardiography improves the accuracy and reproducibility of left ventricular remodeling measurements: a prospective, randomly assigned, blinded study. J Am Coll Cardiol 2001; 38:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/33\">",
"      Daniel GK, Chawla MK, Sawada SG, et al. Echocardiographic imaging of technically difficult patients in the intensive care unit: use of optison in combination with fundamental and harmonic imaging. J Am Soc Echocardiogr 2001; 14:917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/34\">",
"      Yong Y, Wu D, Fernandes V, et al. Diagnostic accuracy and cost-effectiveness of contrast echocardiography on evaluation of cardiac function in technically very difficult patients in the intensive care unit. Am J Cardiol 2002; 89:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/35\">",
"      Mele D, Campana M, Sclavo M, et al. Impact of tissue harmonic imaging in patients with distorted left ventricles: improvement in accuracy and reproducibility of visual, manual and automated echocardiographic assessment of left ventricular ejection fraction. Eur J Echocardiogr 2003; 4:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/36\">",
"      Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/37\">",
"      Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002; 105:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/38\">",
"      Folland ED, Parisi AF, Moynihan PF, et al. Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. A comparison of cineangiographic and radionuclide techniques. Circulation 1979; 60:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/39\">",
"      Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18:1440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/40\">",
"      Helle-Valle T, Crosby J, Edvardsen T, et al. New noninvasive method for assessment of left ventricular rotation: speckle tracking echocardiography. Circulation 2005; 112:3149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/41\">",
"      Mor-Avi V, Lang RM, Badano LP, et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. J Am Soc Echocardiogr 2011; 24:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/42\">",
"      Abraham TP, Nishimura RA. Myocardial strain: can we finally measure contractility? J Am Coll Cardiol 2001; 37:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/43\">",
"      Marwick TH. Measurement of strain and strain rate by echocardiography: ready for prime time? J Am Coll Cardiol 2006; 47:1313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/44\">",
"      Naik MM, Diamond GA, Pai T, et al. Correspondence of left ventricular ejection fraction determinations from two-dimensional echocardiography, radionuclide angiography and contrast cineangiography. J Am Coll Cardiol 1995; 25:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/45\">",
"      Starling MR, Crawford MH, Sorensen SG, et al. Comparative accuracy of apical biplane cross-sectional echocardiography and gated equilibrium radionuclide angiography for estimating left ventricular size and performance. Circulation 1981; 63:1075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/46\">",
"      Gopal AS, Shen Z, Sapin PM, et al. Assessment of cardiac function by three-dimensional echocardiography compared with conventional noninvasive methods. Circulation 1995; 92:842.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/47\">",
"      Nosir YF, Fioretti PM, Vletter WB, et al. Accurate measurement of left ventricular ejection fraction by three-dimensional echocardiography. A comparison with radionuclide angiography. Circulation 1996; 94:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/48\">",
"      Danias PG, Chuang ML, Parker RA, et al. Relation between the number of image planes and the accuracy of three-dimensional echocardiography for measuring left ventricular volumes and ejection fraction. Am J Cardiol 1998; 82:1431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/49\">",
"      Nosir YF, Lequin MH, Kasprzak JD, et al. Measurements and day-to-day variabilities of left ventricular volumes and ejection fraction by three-dimensional echocardiography and comparison with magnetic resonance imaging. Am J Cardiol 1998; 82:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/50\">",
"      K&uuml;hl HP, Schreckenberg M, Rulands D, et al. High-resolution transthoracic real-time three-dimensional echocardiography: quantitation of cardiac volumes and function using semi-automatic border detection and comparison with cardiac magnetic resonance imaging. J Am Coll Cardiol 2004; 43:2083.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/51\">",
"      Jenkins C, Bricknell K, Hanekom L, Marwick TH. Reproducibility and accuracy of echocardiographic measurements of left ventricular parameters using real-time three-dimensional echocardiography. J Am Coll Cardiol 2004; 44:878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/52\">",
"      Corsi C, Lang RM, Veronesi F, et al. Volumetric quantification of global and regional left ventricular function from real-time three-dimensional echocardiographic images. Circulation 2005; 112:1161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/53\">",
"      Williams KA, Taillon LA. Gated planar technetium 99m-labeled sestamibi myocardial perfusion image inversion for quantitative scintigraphic assessment of left ventricular function. J Nucl Cardiol 1995; 2:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/54\">",
"      Borges-Neto S. Perfusion and function assessment by nuclear cardiology techniques. Curr Opin Cardiol 1997; 12:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/55\">",
"      Williams KA, Taillon LA. Left ventricular function in patients with coronary artery disease assessed by gated tomographic myocardial perfusion images. Comparison with assessment by contrast ventriculography and first-pass radionuclide angiography. J Am Coll Cardiol 1996; 27:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/56\">",
"      Constantinesco A, Mertz L, Brunot B. Myocardial perfusion and function imaging at rest with simultaneous thallium-201 and technetium-99m blood-pool dual-isotope gated SPECT. J Nucl Med 1997; 38:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/57\">",
"      Imbriaco M, Cuocolo A, Pace L, et al. Technetium-99m methoxy isobutyl isonitrile simultaneous evaluation of ventricular function and myocardial perfusion in patients with congenital heart disease. Clin Nucl Med 1994; 19:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/58\">",
"      Hamb&yuml;e AS, Dobbeleir A, Vervaet A, Chi-Chou H. Can we rely on 99Tcm-sestamibi gated tomographic myocardial perfusion imaging to quantify left ventricular function? A comparative study with classical isotopic techniques for the measurement of ejection fraction. Nucl Med Commun 1997; 18:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/59\">",
"      Germano G, Kiat H, Kavanagh PB, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995; 36:2138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/60\">",
"      Bavelaar-Croon CD, Pauwels EK, van der Wall EE. Gated single-photon emission computed tomographic myocardial imaging: a new tool in clinical cardiology. Am Heart J 2001; 141:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/61\">",
"      Chua T, Kiat H, Germano G, et al. Gated technetium-99m sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability. Correlation with echocardiography and rest thallium-201 scintigraphy. J Am Coll Cardiol 1994; 23:1107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/62\">",
"      Ioannidis JP, Trikalinos TA, Danias PG. Electrocardiogram-gated single-photon emission computed tomography versus cardiac magnetic resonance imaging for the assessment of left ventricular volumes and ejection fraction: a meta-analysis. J Am Coll Cardiol 2002; 39:2059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/63\">",
"      DePuey EG, Nichols K, Dobrinsky C. Left ventricular ejection fraction assessed from gated technetium-99m-sestamibi SPECT. J Nucl Med 1993; 34:1871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/64\">",
"      Taillefer R, DePuey EG, Udelson JE, et al. Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol 1997; 29:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/65\">",
"      Danias PG, Ahlberg AW, Clark BA 3rd, et al. Combined assessment of myocardial perfusion and left ventricular function with exercise technetium-99m sestamibi gated single-photon emission computed tomography can differentiate between ischemic and nonischemic dilated cardiomyopathy. Am J Cardiol 1998; 82:1253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/66\">",
"      Danias PG, Papaioannou GI, Ahlberg AW, et al. Usefulness of electrocardiographic-gated stress technetium-99m sestamibi single-photon emission computed tomography to differentiate ischemic from nonischemic cardiomyopathy. Am J Cardiol 2004; 94:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/67\">",
"      Nichols K, DePuey EG, Rozanski A, et al. Image enhancement of severely hypoperfused myocardia for computation of tomographic ejection fraction. J Nucl Med 1997; 38:1411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/68\">",
"      Heller GV, Calnon D, Dorbala S. Recent advances in cardiac PET and PET/CT myocardial perfusion imaging. J Nucl Cardiol 2009; 16:962.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/69\">",
"      Dorbala S, Vangala D, Sampson U, et al. Value of vasodilator left ventricular ejection fraction reserve in evaluating the magnitude of myocardium at risk and the extent of angiographic coronary artery disease: a 82Rb PET/CT study. J Nucl Med 2007; 48:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/70\">",
"      Dorbala S, Hachamovitch R, Curillova Z, et al. Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF. JACC Cardiovasc Imaging 2009; 2:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/71\">",
"      Lertsburapa K, Ahlberg AW, Bateman TM, et al. Independent and incremental prognostic value of left ventricular ejection fraction determined by stress gated rubidium 82 PET imaging in patients with known or suspected coronary artery disease. J Nucl Cardiol 2008; 15:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/72\">",
"      Jahnke C, Nagel E, Gebker R, et al. Four-dimensional single breathhold magnetic resonance imaging using kt-BLAST enables reliable assessment of left- and right-ventricular volumes and mass. J Magn Reson Imaging 2007; 25:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/73\">",
"      Pini R, Giannazzo G, Di Bari M, et al. Transthoracic three-dimensional echocardiographic reconstruction of left and right ventricles: in vitro validation and comparison with magnetic resonance imaging. Am Heart J 1997; 133:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/74\">",
"      Markiewicz W, Sechtem U, Kirby R, et al. Measurement of ventricular volumes in the dog by nuclear magnetic resonance imaging. J Am Coll Cardiol 1987; 10:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/75\">",
"      Go RT, MacIntyre WJ, Yeung HN, et al. Volume and planar gated cardiac magnetic resonance imaging: a correlative study of normal anatomy with thallium-201 SPECT and cadaver sections. Radiology 1984; 150:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/76\">",
"      Bellenger NG, Burgess MI, Ray SG, et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J 2000; 21:1387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/77\">",
"      Cranney GB, Lotan CS, Dean L, et al. Left ventricular volume measurement using cardiac axis nuclear magnetic resonance imaging. Validation by calibrated ventricular angiography. Circulation 1990; 82:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/78\">",
"      Weiss JL, Shapiro EP, Buchalter MB, Beyar R. Magnetic resonance imaging as a noninvasive standard for the quantitative evaluation of left ventricular mass, ischemia, and infarction. Ann N Y Acad Sci 1990; 601:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/79\">",
"      Lawson MA, Blackwell GG, Davis ND, et al. Accuracy of biplane long-axis left ventricular volume determined by cine magnetic resonance imaging in patients with regional and global dysfunction. Am J Cardiol 1996; 77:1098.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/80\">",
"      Koch K, Oellig F, Oberholzer K, et al. Assessment of right ventricular function by 16-detector-row CT: comparison with magnetic resonance imaging. Eur Radiol 2005; 15:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/81\">",
"      Mahnken AH, Hohl C, Suess C, et al. Influence of heart rate and temporal resolution on left-ventricular volumes in cardiac multislice spiral computed tomography: a phantom study. Invest Radiol 2006; 41:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/82\">",
"      Juergens KU, Grude M, Maintz D, et al. Multi-detector row CT of left ventricular function with dedicated analysis software versus MR imaging: initial experience. Radiology 2004; 230:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/83\">",
"      Raman SV, Shah M, McCarthy B, et al. Multi-detector row cardiac computed tomography accurately quantifies right and left ventricular size and function compared with cardiac magnetic resonance. Am Heart J 2006; 151:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/84\">",
"      Sugeng L, Mor-Avi V, Weinert L, et al. Quantitative assessment of left ventricular size and function: side-by-side comparison of real-time three-dimensional echocardiography and computed tomography with magnetic resonance reference. Circulation 2006; 114:654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/21/11610/abstract/85\">",
"      Domanski MJ, Nanda N. Echocardiographic determination of left ventricular function. J Am Soc Echocardiogr 2006; 19:941.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5331 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.234.146.186-4FB60DB4AC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_21_11610=[""].join("\n");
var outline_f11_21_11610=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H31\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      RADIONUCLIDE VENTRICULOGRAPHY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Blood pool labeling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Equilibrium RVG",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Advantages",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Limitations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      First-pass RVG",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Advantages",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Limitations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Combined first-pass RVG and SPECT perfusion imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      ECHOCARDIOGRAPHY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Qualitative global function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Qualitative regional function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Quantitative evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Assessment of myocardial strain and strain-rate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Accuracy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Advantages",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Disadvantages",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Three dimensional echocardiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      GATED SINGLE PHOTON EMISSION TOMOGRAPHY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Accuracy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Advantages",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Disadvantages",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26431337\">",
"      ECG gated PET imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      CARDIOVASCULAR MAGNETIC RESONANCE IMAGING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Advantages",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Disadvantages",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      COMPUTED TOMOGRAPHY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/5331\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/5331|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?43/41/44693\" title=\"diagnostic image 1\">",
"      Equilibrium RVG",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?7/17/7442\" title=\"diagnostic image 2\">",
"      First pass RVG",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?18/34/18982\" title=\"diagnostic image 3\">",
"      Estimation of LV volumes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?15/47/16115\" title=\"diagnostic image 4\">",
"      Three dimensional LV blood pool",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/5331|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/49/4894\" title=\"figure 1\">",
"      Exercise EF survival CHD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/36/6722\" title=\"figure 2\">",
"      Sites LV measurements",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?1/21/1360\" title=\"figure 3\">",
"      LV wall motion analysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/55/26487\" title=\"figure 4\">",
"      LV segmentation I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?33/26/34221\" title=\"figure 5\">",
"      CHD ECG gated SPECT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/5331|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/10/19628\" title=\"table 1\">",
"      ACC AHA LV function CAD",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/24/28040?source=related_link\">",
"      Acute cardiac allograft rejection: Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/33/23066?source=related_link\">",
"      Assessment of myocardial viability by nuclear imaging in coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/23/35192?source=related_link\">",
"      Basic properties of myocardial perfusion agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/56/18314?source=related_link\">",
"      Cardiac resynchronization therapy in heart failure: Indications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/46/41706?source=related_link\">",
"      Cardiotoxicity of anthracycline-like chemotherapy agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/12/40138?source=related_link\">",
"      Cardiotoxicity of nonanthracycline cancer chemotherapy agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/22/43368?source=related_link\">",
"      Clinical manifestations and diagnosis of diastolic heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/3/34874?source=related_link\">",
"      Clinical utility of cardiovascular magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/53/13145?source=related_link\">",
"      Contrast echocardiography: Clinical applications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/41/10905?source=related_link\">",
"      Evaluation of hibernating myocardium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/24/24970?source=related_link\">",
"      Exercise radionuclide myocardial perfusion imaging in the diagnosis and prognosis of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/24/20874?source=related_link\">",
"      Incidence of and risk stratification for sudden cardiac death after acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/48/33546?source=related_link\">",
"      Predictors of survival in heart failure due to systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/0/15365?source=related_link\">",
"      Principles of Doppler echocardiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/35/5689?source=related_link\">",
"      Principles of magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27466?source=related_link\">",
"      Stress echocardiography in the diagnosis and prognosis of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/38/23146?source=related_link\">",
"      Three-dimensional echocardiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/45/7897?source=related_link\">",
"      Tissue Doppler echocardiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/49/24342?source=related_link\">",
"      Transthoracic echocardiography for the evaluation of chest pain in the emergency department",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_21_11611="Performance of fFN vs clinical assessment for predicting PTD";
var content_f11_21_11611=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F64332&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F64332&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Performance of fetal fibronectin versus clinical assessment of for predicting preterm delivery",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Parameter",
"       </td>",
"       <td class=\"subtitle1\">",
"        Sensitivity (percent)",
"       </td>",
"       <td class=\"subtitle1\">",
"        PPV (percent)",
"       </td>",
"       <td class=\"subtitle1\">",
"        NPV (percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fetal fibronectin",
"       </td>",
"       <td>",
"        93",
"       </td>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        99",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cervical dilatation &gt;1 cm",
"       </td>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        11",
"       </td>",
"       <td>",
"        94",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Contraction frequency &ge;8/h",
"       </td>",
"       <td>",
"        42",
"       </td>",
"       <td>",
"        9",
"       </td>",
"       <td>",
"        94",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     PPV: positive predictive value; NPV: negative predictive value.",
"     <br>",
"      Data derived from symptomatic women and reflect the ability to predict delivery within seven days.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Iams, JD, Casal, D, McGregor, JA, et al. Am J Obstet Gynecol 1995; 173:141.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_21_11611=[""].join("\n");
var outline_f11_21_11611=null;
var title_f11_21_11612="Noninfectious causes of cervical nodes";
var content_f11_21_11612=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F77911&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F77911&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Noninfectious causes of cervical lymphadenitis in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Malignancy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lymphomas",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Leukemia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Neuroblastoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Rhabdomyosarcoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Thyroid cancer",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Collagen vascular disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Juvenile idiopathic arthritis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Systemic lupus erythematosus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Drugs",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Phenytoin",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Carbamazepine",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Miscellaneous",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Kawasaki disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            PFAPA",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Kikuchi-Fujimoto disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Histiocytosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Castleman disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Kimura disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Postvaccination",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sarcoidosis",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     PFAPA: periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_21_11612=[""].join("\n");
var outline_f11_21_11612=null;
var title_f11_21_11613="ASD CAM therapies";
var content_f11_21_11613=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F81572&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F81572&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Examples of complementary and alternative medicine therapies used for autism spectrum disorders",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Mind-body medicine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acupuncture*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Auditory integration training",
"        <sup>",
"         *",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Biofeedback and neurofeedback",
"        <sup>",
"         *",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Electroencephalography",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypnosis",
"        <sup>",
"         *",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Interactive metronome",
"        <sup>",
"         *",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Music therapy*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neuromodulation",
"        <sup>",
"         *",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Yoga*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Biologically based practices",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Antibiotics, antifungals",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Live cell and stem cell therapy",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chelation",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diet (may include probiotics, yeast-free, gluten-free/casein-free, specific carbohydrate diet, vitamin, mineral, and other dietary supplements, etc)",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Digestive enzymes",
"        <sup>",
"         *",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gamma-aminobutyric acid (GABA)",
"        <sup>",
"         *",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Homeopathy",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hyperbaric oxygen therapy (HBOT)",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intravenous immune globulin (IVIG)",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Secretin",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Supplements: carnitine, coenzyme Q, dimethylglycine, folinic acid, lysine, melatonin, omega-3 fatty acids, trimethylglycine, tuarine, vitamin B6-magnesium, vitamin B12",
"        <sup>",
"         *",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Manipulation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chiropractic",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Craniosacral manipulation",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Massage/touch therapy/craniosacral therapy*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Qigong*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Body-based practices, energy medicine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prayer*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hippotherapy (therapeutic horseback riding)*",
"        <sup>",
"         &yen;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Transcranial magnetic stimulation",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Miscellaneous",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Facilitated communication",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * There is little evidence of efficacy or safety; clinicians and families must weigh the unknown benefit against the potential risks (including competition with validated therapies for time, effort, and financial resources).",
"     <br>",
"      &Delta; There is little evidence that these treatments are effective but they have the potential to be harmful.",
"      <br>",
"       <font class=\"lozenge\">",
"        &loz;",
"       </font>",
"       There little evidence that these treatments are effective, but they have the potential for serious adverse events.",
"       <br>",
"        &sect; There is good evidence that these therapies are not effective.",
"        <br>",
"         &yen; Therapeutic horseback riding is associated with a risk of injury similar to that in other \"limited contact\" recreational activities (eg, baseball, skating); appropriate supervision is necessary.",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_21_11613=[""].join("\n");
var outline_f11_21_11613=null;
var title_f11_21_11614="Occupational agents causing adverse pregnancy outcomes";
var content_f11_21_11614=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F51370%7EOBGYN%2F64742&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F51370%7EOBGYN%2F64742&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Occupational agents causing adverse pregnancy outcomes",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Agent",
"      </td>",
"      <td class=\"subtitle1\">",
"       Outcome seen in human studies",
"      </td>",
"      <td class=\"subtitle1\">",
"       Outcome seen in animal studies",
"      </td>",
"      <td class=\"subtitle1\">",
"       Data*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Anesthetic gases",
"      </td>",
"      <td>",
"       Spontaneous abortion",
"      </td>",
"      <td>",
"       Birth defects",
"      </td>",
"      <td>",
"       1,3",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Antineoplastic drugs",
"      </td>",
"      <td>",
"       Spontaneous abortion",
"      </td>",
"      <td>",
"       Birth defects, fetal loss",
"      </td>",
"      <td>",
"       1,3,5",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Arsenic",
"      </td>",
"      <td>",
"       Spontaneous abortion, low birth weight",
"      </td>",
"      <td>",
"       Birth defects, fetal loss",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Benzo(a)pyrene",
"      </td>",
"      <td>",
"       None",
"      </td>",
"      <td>",
"       Birth defects",
"      </td>",
"      <td>",
"       1",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cadmium",
"      </td>",
"      <td>",
"       Low birth weight, skeletal disease",
"      </td>",
"      <td>",
"       Fetal loss, birth defects",
"      </td>",
"      <td>",
"       2, 3",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Carbon disulfide",
"      </td>",
"      <td>",
"       Menstrual disorders, spontaneous abortion",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Carbon monoxide (CO)",
"      </td>",
"      <td>",
"       None specific to CO",
"      </td>",
"      <td>",
"       Birth defects, low birth weight",
"      </td>",
"      <td>",
"       2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Chlordecone",
"      </td>",
"      <td>",
"       None",
"      </td>",
"      <td>",
"       Fetal loss",
"      </td>",
"      <td>",
"       2, 5",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Chloroform",
"      </td>",
"      <td>",
"       Eclampsia",
"      </td>",
"      <td>",
"       Fetal loss",
"      </td>",
"      <td>",
"       1",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Chloroprene",
"      </td>",
"      <td>",
"       None",
"      </td>",
"      <td>",
"       Birth defects",
"      </td>",
"      <td>",
"       2, 3, 5",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ethylene glycol ethers",
"      </td>",
"      <td>",
"       None",
"      </td>",
"      <td>",
"       Fetal loss",
"      </td>",
"      <td>",
"       2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ethylene oxide",
"      </td>",
"      <td>",
"       Spontaneous abortion",
"      </td>",
"      <td>",
"       Fetal loss",
"      </td>",
"      <td>",
"       1,3",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Formamides",
"      </td>",
"      <td>",
"       None",
"      </td>",
"      <td>",
"       Fetal loss, birth defects",
"      </td>",
"      <td>",
"       2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Inorganic mercury",
"      </td>",
"      <td>",
"       Spontaneous abortion",
"      </td>",
"      <td>",
"       Fetal loss",
"      </td>",
"      <td>",
"       1, 3",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Lead",
"      </td>",
"      <td>",
"       Spontaneous abortion, prematurity, neurological dysfunction in child",
"      </td>",
"      <td>",
"       Birth defects, fetal loss",
"      </td>",
"      <td>",
"       2, 4",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Organic mercury",
"      </td>",
"      <td>",
"       Cerebral palsy, CNS malformation",
"      </td>",
"      <td>",
"       Birth defects, fetal loss",
"      </td>",
"      <td>",
"       2, 4",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ozone",
"      </td>",
"      <td>",
"       None",
"      </td>",
"      <td>",
"       Fetal loss",
"      </td>",
"      <td>",
"       1",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Physical stress",
"      </td>",
"      <td>",
"       Prematurity",
"      </td>",
"      <td>",
"       None",
"      </td>",
"      <td>",
"       4",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Polybrominated biphenyis (PBBs)",
"      </td>",
"      <td>",
"       None",
"      </td>",
"      <td>",
"       Fetal loss",
"      </td>",
"      <td>",
"       2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Mixed solvents",
"      </td>",
"      <td>",
"       Spontaneous abortion, CNS defects",
"      </td>",
"      <td>",
"       Spontaneous abortion, CNS defects",
"      </td>",
"      <td>",
"       2, 3, 7",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Radiation",
"      </td>",
"      <td>",
"       CNS defects, skeletal abnormalities",
"      </td>",
"      <td>",
"       Fetal loss, birth defects",
"      </td>",
"      <td>",
"       2, 4",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Selenium",
"      </td>",
"      <td>",
"       Spontaneous abortion",
"      </td>",
"      <td>",
"       Low birth weight",
"      </td>",
"      <td>",
"       2,7",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Tellerium",
"      </td>",
"      <td>",
"       None",
"      </td>",
"      <td>",
"       Birth defects",
"      </td>",
"      <td>",
"       2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       2, 4-D",
"      </td>",
"      <td>",
"       Skeletal defects",
"      </td>",
"      <td>",
"       Birth defects",
"      </td>",
"      <td>",
"       1, 3, 8",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Video display terminals",
"      </td>",
"      <td>",
"       Spontaneous abortion",
"      </td>",
"      <td>",
"       Birth defects",
"      </td>",
"      <td>",
"       1, 8",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Vinyl chloride",
"      </td>",
"      <td>",
"       CNS defects",
"      </td>",
"      <td>",
"       None",
"      </td>",
"      <td>",
"       3, 6",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Xylene",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       Fetal loss",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * 1: limited positive animal data; 2: strong positive animal data; 3: limited positive human data; 4: strong positive human data; 5: limited negative animal data; 6: strong negative animal data; 7: limited negative human data; 8: strong negative human data.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Welch, L. In: Preventing Occupational Disease and Injury, 2nd Edition, Levy, BS, Wagner, GR, Rest, KM, Weeks, JL (Eds). American Public Health Association, Washington, DC 2005. Copyright &copy; 2005 American Public Health Association.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Chemical and physical agents that are reproductive hazards for women in the workplace",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Agent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Observed effects",
"       </td>",
"       <td class=\"subtitle1\">",
"        Potentially exposed workers",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cancer treatment drugs (eg., methotrexate)",
"       </td>",
"       <td>",
"        Infertility, miscarriage, birth defects, low birth weight",
"       </td>",
"       <td>",
"        Health care workers, pharmacists",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Certain ethylene glycol ethers such as:",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Miscarriage",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Electronic and semiconductor workers",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        2-ethoxyethanol (2EE) and",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        2-methoxyethanol (2ME)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carbon disulfide (CS2)",
"       </td>",
"       <td>",
"        Menstrual cycle changes",
"       </td>",
"       <td>",
"        Viscose rayon workers",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lead",
"       </td>",
"       <td>",
"        Infertility, miscarriage, low birth weight, developmental disorders",
"       </td>",
"       <td>",
"        Battery makers, solderers, welders, radiator repairers, bridge repainters, firing range workers, home remodelers",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ionizing radiation (eg., X-rays and gamma rays)",
"       </td>",
"       <td>",
"        Infertility, miscarriage, birth defects, low birth weight, developmental disorders, childhood cancers",
"       </td>",
"       <td>",
"        Health care workers, dental personnel, atomic workers",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Strenuous physical labor (eg., prolonged standing, heavy lifting)",
"       </td>",
"       <td>",
"        Miscarriage, premature delivery",
"       </td>",
"       <td>",
"        Many types of workers",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     National Institute for Occupational Safety and Health.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_21_11614=[""].join("\n");
var outline_f11_21_11614=null;
var title_f11_21_11615="Penetrating neck injury through platysma algorithm";
var content_f11_21_11615=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F51111&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F51111&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 513px\">",
"   <div class=\"ttl\">",
"    Algorithm for penetrating neck injury through the platysma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 493px; height: 407px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CXR: chest x-ray; MDCT-A: multidetector computed tomography with angiography; OR: operating room.",
"     <br>",
"      * Preferred imaging studies vary by institution and local expertise.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_21_11615=[""].join("\n");
var outline_f11_21_11615=null;
